amlodipine has been researched along with hydrochlorothiazide in 358 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (1.40) | 18.7374 |
1990's | 21 (5.87) | 18.2507 |
2000's | 88 (24.58) | 29.6817 |
2010's | 219 (61.17) | 24.3611 |
2020's | 25 (6.98) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Caron, G; Ermondi, G; Lorenti, M | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Rofman, BA | 1 |
Ames, RP; Applegate, WB; Burris, JF; Davidov, ME; Mroczek, WJ; Ram, CV | 2 |
Chrysant, SG; Glasser, SP; Graves, J; Koehn, DK; Rofman, B | 1 |
Chrysant, C; Chrysant, SG; Hitchcock, A; Trus, J | 1 |
Osterloh, I | 1 |
Adegbile, IA; Alemayehu, D; Carr, AA; Lefkowitz, MP; Papademetriou, V; Prisant, LM; Weber, MA; Weir, MR | 1 |
Ajayi, AA; Akintomide, AO | 1 |
Fogari, R; Malamani, GD; Marasi, G; Vanasia, A; Villa, G; Zoppi, A | 1 |
Agbedana, EO; Ahaneku, JE; Salako, LA; Taylor, GO; Walker, O | 1 |
Adolphe, AB; Brescia, D; Rofman, BA; Vlachakis, ND; Zellner, SR | 1 |
Amery, A; Staessen, J | 1 |
Agbedana, OE; Ahaneku, JE; Taylor, OG | 1 |
Dees, A; Derkx, FH; Krijnen, P; Man in't Veld, AJ; Pieterman, H; Postma, CT; Schalekamp, MA; van Jaarsveld, BC; Woittiez, AJ | 1 |
Le Bloch, Y; Waeber, B; Weidmann, P; Wohler, D | 1 |
Ahaneku, JE | 1 |
Agbedana, EO; Ahaneku, JE; Salako, LA; Sowunmi, A; Taylor, GO; Walker, O | 1 |
Archambault, F; Boileau, G; Cléroux, J; Lacourcière, Y; Lefebvre, J; Poirier, L | 1 |
Cléroux, J; Lacourcière, Y; Poirier, L | 1 |
Furberg, CD; Pahor, M; Psaty, BM | 1 |
Neutel, JM; Papademetriou, V; Prisant, LM; Weir, MR | 1 |
Drewe, J; Gasser, P; Martina, B; Weinbacher, M | 1 |
DeQuattro, V; Ferdinand, K; Hall, WD; Neutel, JM; Papademetriou, V; Prisant, LM; Weir, MR | 1 |
Sever, PS | 1 |
DeQuattro, V; Hall, WD; Neutel, JM; Papademetriou, V; Prisant, LM; Weir, MR | 1 |
Battegay, E; Dieterle, T; Martina, B; Weinbacher, M | 1 |
Grote, L; Hedner, J; Kraiczi, H; Peker, Y | 1 |
Fukuzawa, M; Miyaguchi, S; Nakazawa, T; Ohta, S; Qiang, X; Sakata, Y; Satoh, J; Takahashi, K; Takizawa, Y; Toyota, T | 1 |
Antonios, TF; He, FJ; MacGregor, GA; Viskoper, JR | 1 |
Benetos, A; Consoli, S; Dubanchet, A; Safar, M; Safavian, A | 1 |
Abate, G; Calvo-Gomez, C; Chastang, C; Emeriau, JP; Knauf, H; Leonetti, G; Pujadas, JO | 1 |
Bertocchi, F; Bonaduce, D; Carretta, R; Condorelli, M; Fogari, R; Malacco, E; Mann, J; Palatini, P | 1 |
Deinum, J; Derkx, FH; Krijnen, P; Postma, CT; Schalekamp, MA; van Jaarsveld, BC; Woittiez, AJ | 1 |
Bertocchi, F; Carretta, R; Di, SS; Dorigatti, F; Malacco, E; Mann, J; Palatini, P | 1 |
Bertocchi, F; Carretta, R; Di Somma, S; Malacco, E; Mugellini, A; Palatini, P; Piazza, S | 1 |
Ambrosioni, E | 1 |
Burns, D; Kleiman, J; Krause, S; Phillips, RA; Pitt, B; Reichek, N; Roniker, B; Willenbrock, R; Williams, GH; Zannad, F | 1 |
Borgnino, C; Capuano, V; Malacco, E; Palatini, P; Spagnuolo, V; Varì, N | 1 |
Franco, RJ; Goldflus, S; McQuitty, M; Oigman, W | 1 |
Ambrosia, GB; Caiazza, A; Malacco, E; Mugellini, A; Palatini, P; Santonastaso, M; Spagnuolo, V | 1 |
Brunner, HR; Ekman, S; Hansson, L; Hua, T; Julius, S; Kjeldsen, SE; Laragh, J; McInnes, GT; Mitchell, L; Plat, F; Schork, A; Smith, B; Weber, M; Zanchetti, A | 1 |
Bakris, GL; McCullough, PA; Toto, RD | 1 |
Weder, AB | 1 |
Brandão, AA; Heintz, D; Kandra, A; Khder, Y; Ruilope, LM; Santonastaso, M; Stolt, P | 1 |
Abate, G; Calvo-Gomez, C; Emeriau, JP; Knauf, H; Leonetti, G; Pujadas, JO | 1 |
Bönner, G; Heintz, D; Kandra, A; Khder, Y; Malacco, E; Ruilope, LM | 1 |
Daley, W; Ferdinand, KC; Flack, JM; Jamerson, KA; Weir, MR; Zelenkofske, S | 1 |
Lee, Y; Neutel, JM; Silfani, TN; Smith, DH; Weber, MA | 1 |
Bertoluci, MC; Oliveira, FR; Schmid, H; Schmidt, A; Thomazelli, FC; Uebel, D | 1 |
Chavanu, K; Merkel, J; Quan, A | 1 |
Jaimes, EA; Raij, L; Zhou, MS | 1 |
Ruilope, LM; Zanchetti, A | 1 |
Coelho, EB; da Silva, CA; Fazan, R; Nobre, F; Salgado, HC | 1 |
Bizot, MN; Denouel, J; Dieterich, HA; Dole, WP; Kemp, C; Vaidyanathan, S; Valencia, J; Yeh, CM; Zhao, C | 1 |
Hannila-Handelberg, T; Hiltunen, TP; Kontula, K; Miettinen, HE; Paavonen, KJ; Pentikäinen, PJ; Strandberg, T; Suonsyrjä, T; Tikkanen, I; Tilvis, R; Virolainen, J | 1 |
Boye, SW; Engeli, S; Jordan, J; Keefe, DL; Le Breton, S | 1 |
Abe, C; Akashiba, A; Ishimitsu, T; Kameda, T; Matsuoka, H; Minami, J; Takahashi, T | 1 |
Bakris, GL; Dahlöf, B; Gupte, J; Hester, A; Jamerson, K; Kjeldsen, S; Lefkowitz, M; Massie, B; Nesbitt, S; Ofili, E; Pitt, B; Shi, V; Velazquez, E; Weber, MA; Weir, M | 1 |
Chiara Cavallini, M; Palmieri, V; Pini, R | 1 |
Chiang, YT; Fomina, I; Gamboa, R; Glazes, R; Kaczor, J; Kargiannis, S; Poldermans, D; Wernsing, M; Yen, J | 1 |
Bakris, GL; Cushman, W; Dahlöf, B; Gupte, J; Hester, A; Jamerson, K; Kjeldsen, SE; Lefkowitz, M; Papademetriou, V; Pitt, B; Shi, V; Velazquez, E; Weber, M | 1 |
Fornoni, A; Lenz, O; Materson, BJ; Tejada, T | 1 |
Derosa, G; Fogari, R; Mugellini, A | 1 |
Dubiel, R; Kereiakes, DJ; Lipka, LJ; Neutel, JM; Punzi, HA; Xu, J | 1 |
Fujita, T; Gohchi, K; Shimosawa, T; Yatomi, Y | 1 |
Allemann, Y; Barbier, M; Ferber, P; Fraile, B; Izzo, JL; Lambert, M | 1 |
Ferreira, SR; Kohlmann, NE; Kohlmann, O; Plavnik, FL; Ribeiro, AB; Rosa, EC; Zanella, MT | 1 |
Bakris, GL; Davis, P; McCullough, PA; Purkayastha, D; Rocha, R; Toto, RD | 1 |
Botha, J; DeAngelis, L; Ferber, P; Kandra, A; Karalliedde, J; Mirenda, V; Smith, A; Viberti, G | 1 |
Donner, K; Hannila-Handelberg, T; Hiltunen, TP; Kontula, K; Miettinen, HE; Paavonen, KJ; Pentikäinen, PJ; Strandberg, T; Suonsyrjä, T; Tikkanen, I; Tilvis, R | 1 |
Ferguson, JM; Komesaroff, PA; Minas, J; Siapantas, S; Sudhir, K | 1 |
Smith, DH | 1 |
Einecke, D | 1 |
Bakris, GL; Dahlöf, B; Gupte, J; Hester, A; Hua, TA; Ibsen, H; Jamerson, KA; Kjeldsen, SE; Ostergren, J; Pitt, B; Shi, V; Staikos, L; Tuomilehto, J; Velazquez, EJ; Weber, M | 1 |
Aumiller, J | 1 |
Dabek, J; Hannila-Handelberg, T; Hiltunen, TP; Kontula, K; Nieminen, MS; Oikarinen, L; Porthan, K; Suonsyrja, T; Toivonen, L; Vaananen, H; Viitasalo, M; Virolainen, J | 1 |
Mourad, JJ; Waeber, B | 1 |
Brixner, DI; Jackson, KC; Keskinaslan, A; Nelson, RE; Sheng, X | 1 |
Amodeo, C; Brandão, AA; Feitosa, AD; Gomes, MA; Moriguchi, EH; Oigman, W; Précoma, DB; Ribeiro, AB; Ribeiro, JM; Saraiva, JF | 1 |
Kuzmanić, M; Pavlicević, I; Rumboldt, M; Rumboldt, Z | 1 |
Bakris, G; Dahlof, B; Hester, A; Jamerson, K; Pitt, B; Shi, V; Staikos-Byrne, L; Velasquez, E; Weber, M | 1 |
Bakris, GL; Dahlöf, B; Gatlin, M; Gupte, J; Hester, A; Jamerson, K; Pitt, B; Shi, V; Velazquez, EJ; Weber, MA | 1 |
Chobanian, AV | 1 |
Donner, K; Fodstad, H; Hannila-Handelberg, T; Hiltunen, TP; Kontula, K; Suonsyrjä, T | 1 |
Basile, JN; Carter, BL; Ernst, ME | 1 |
Barbier, M; Brunel, P; Calhoun, DA; Flack, JM; Hilkert, R; Satlin, L | 1 |
Feihl, F; Waeber, B | 1 |
Cohen, DL; Townsend, RR | 1 |
Preobrazhenskiĭ, DV | 1 |
Parra, D; Rosenstein, R | 1 |
Newton, GE; Strauss, MH; Weinstein, J | 1 |
Davis, BR; Whelton, PK | 1 |
Black, HR; Lacourcière, Y; Purkayastha, D; Samuel, R; Wright, JT; Zappe, D | 2 |
Haag, U; Miele, C; Volpe, M | 1 |
Asmar, R; Baguet, JP; Mallion, JM; Nisse-Durgeat, S; Valensi, P | 1 |
Black, HR | 1 |
Calhoun, DA; Chiang, YT; Glazer, RD; Lacourcière, Y | 1 |
Ando, K; Isshiki, M; Takahashi, K | 1 |
Siragy, HM | 1 |
Devereux, RB; Hall, D; Hilkert, R; Pitt, B; Purkayastha, D; Reichek, N; Rocha, RA | 1 |
Izzo, JL | 1 |
Dutta, TK; Madanmohan, T; Pavithran, P; Prakash, ES | 1 |
Ferber, P; Papst, CC; Zappe, D | 1 |
de Leeuw, PW; Kessels, AG; Kroon, AA; Neef, C; van der Kuy, PH; van Onzenoort, HA; Verberk, WJ | 1 |
Deeks, ED | 2 |
de Leeuw, PW; Kessels, AG; Kroon, AA; Neef, C; Nelemans, PJ; van der Kuy, PH; van Onzenoort, HA; Verberk, WJ | 1 |
Day, AG; Ogunyankin, KO | 1 |
Calhoun, DA; Crikelair, NA; Glazer, RD; Yen, J | 1 |
Bakris, GL; Chiang, YT; Dahlöf, B; Jamerson, K; Kelly, RY; Pitt, B; Sarafidis, PA; Shi, V; Staikos-Byrne, L; Velazquez, EJ; Weber, MA; Weir, MR | 1 |
de Zeeuw, D; Heerspink, HL | 1 |
Chrysant, SG; Heyrman, R; Karki, S; Lee, J; Melino, M; Oparil, S | 1 |
Cagnoni, F; D'Ospina, A; Demichele, E; Destro, M; Peros, E; Preti, P; Ricci, AR; Zaninelli, A | 1 |
Deng, Q; Liu, L; Liu, M; Ma, L; Wang, W; Zhang, Y | 1 |
Arif, AF; Joshi, C; Kadam, GG | 1 |
Deedwania, PC; Egan, BM; Jialal, I; Ofili, EO; Purkayastha, D; Raij, L; Samuel, R; Sowers, JR; Zappe, DH | 1 |
Bakris, GL; Jamerson, KA; Weber, MA | 1 |
Bakris, GL; Dahlöf, B; Devereux, RB; Hester, A; Hua, TA; Jamerson, K; Kelly, RY; Kjeldsen, SE; Pitt, B; Velazquez, EJ; Weber, MA; Weir, M | 1 |
Fernandez, V; Heyrman, R; Lee, J; Melino, M; Oparil, S | 1 |
Laverman, GD; Navis, G; Slagman, MC | 1 |
Ayalasomayajula, S; Bhad, P; Jarugula, V; Karan, R; Leon, S; Riviere, GJ; Sunkara, G | 1 |
Crikelair, N; Destro, M; Glazer, R; Yen, J | 1 |
Barrios, V; Escobar, C | 1 |
Jin, D; Miyazaki, M; Sakonjo, H; Shimosato, T; Takai, S | 1 |
Comi-Diaz, C; Martinez-Martin, FJ; Pedrianes-Martin, P; Peiro-Martinez, I; Rodriguez-Rosas, H; Soriano-Perera, P | 1 |
Benduhn, H; Klebs, S; Schweizer, J; Ulmer, HJ | 1 |
Divya, O; Nagavalli, D; Sankar, AS; Santha, A; Vaidhyalingam, V | 1 |
Ram, CV | 1 |
Bakris, GL; Dahlöf, B; Devereux, R; Hester, A; Hua, TA; Jamerson, KA; Kelly, RY; Pitt, B; Velazquez, EJ; Weber, MA; Weir, M | 1 |
Belavic, JM | 1 |
Calhoun, DA; Crikelair, N; Glazer, RD; Lacourcière, Y; Yen, J | 1 |
Hosseini, F; Mahmoudian, M; Nemati, F; Rahbar-Roshandel, N; Shafiei, M | 1 |
Makris, T; Stefanadis, C; Thomopoulos, C; Tsioufis, C | 1 |
McInnes, GT | 1 |
Balink, H; de Graaf, W; Grond, J; Hemmelder, MH | 1 |
Jia, M; Ran, H; Tang, H; Wang, H; Wang, X; Yang, C; Zeng, C; Zeng, J; Zhang, J; Zhang, Y | 1 |
Chrysant, SG | 3 |
Aderibigbe, A; Anisiuba, BC; Ba, SA; Boombhi, HJ; Ijoma, CK; Kamdem, MK; Kaptue, J; Kingue, S; Kolo, PM; Lemogoum, D; M'buyamba-Kabangu, JR; Mipinda, JB; Ndiaye, MB; Odili, AN; Omotoso, BA; Richart, T; Staessen, JA; Thijs, L; Ulasi, II | 1 |
Littlejohn, T; Neutel, JM; Qian, C; Ram, CV; Sachson, R; Shojaee, A; Stoakes, KA | 1 |
Ferdinand, KC; Pool, J; Purkayastha, D; Townsend, R; Weitzman, R | 1 |
Bamias, A; Constantinidis, C; Deliveliotis, C; Dimopoulos, MA; Karadimou, A; Lainakis, G; Manios, E; Michas, F; Zakopoulos, N | 1 |
Graff, A; Hsueh, WA; Jones, CJ; Littlejohn, TJ; Nesbitt, SD; Neutel, JM; Qian, C; Shojaee, A; Waverczak, WF; Weir, MR | 1 |
Duprez, D; Ferdinand, KC; Purkayastha, D; Samuel, R; Wright, RF | 1 |
Bakris, GL; Dahlöf, B; Hester, A; Hua, TA; Ibsen, H; Jamerson, KA; Kelly, RY; Kjeldsen, SE; Ostergren, J; Pitt, B; Tuomilehto, J; Velazquez, EJ; Weber, M; Zappe, D | 1 |
Narkiewicz, K | 1 |
Baek, I; Drummond, W; Keefe, DL; Ramos, E; Sirenko, YM | 1 |
Kawecka-Jaszcz, K; Rajzer, M; Undas, A; Wojciechowska, W | 1 |
Egan, BM; Purkayastha, D; Raij, L; Samuel, R; Sowers, JR; Zappe, DH | 1 |
Donner, KM; Hannila-Handelberg, T; Hiltunen, TP; Kontula, K; Suonsyrjä, T | 1 |
Huang, J; Matavelli, LC; Siragy, HM | 1 |
Christogiannis, LG; Elisaf, MS; Kostapanos, MS; Milionis, HJ; Tellis, CC; Tselepis, AD | 1 |
Chrysant, SG; Fernandez, V; Heyrman, R; Izzo, JL; Kereiakes, DJ; Lee, J; Littlejohn Iii, T; Melino, M; Oparil, S | 1 |
Bhosekar, V; Forker, AD; Keefe, DL; Townsend, RR; Yadao, A | 1 |
Duprez, D; Ferdinand, K; Purkayastha, D; Samuel, R; Wright, R | 1 |
Bakris, GL; Dahlof, B; Devereux, RB; Hester, RA; Hua, TA; Jamerson, KA; Kelly, RY; Kjeldsen, SE; Pitt, B; Velazquez, E; Weber, MA; Weir, MR; Wright, JT | 1 |
Ofili, EO; Purkayastha, D; Samuel, R; Sowers, JR; Zappe, DH | 1 |
Berwanger, O; Mion Júnior, D; Ortega, KC; Silva, GV; Tsuji, RL | 1 |
Deng, Q; Liu, L; Liu, M; Ma, L; Sun, H; Wang, J; Wang, W; Zhang, Y; Zhao, Y | 1 |
Derosa, G; Fogari, R; Maffioli, P; Mugellini, A; Perrone, T; Preti, P; Zoppi, A | 1 |
Chrysant, SG; Fernandez, V; Heyrman, R; Izzo, JL; Kereiakes, DJ; Lee, J; Littlejohn, T; Melino, M; Oparil, S | 2 |
Jaimes, EA; Judd, E | 1 |
Pancholi, SS; Sharma, RN | 1 |
Sun, CX; Tao, CW; Wu, ZB; Yu, QG; Zhang, Y | 1 |
Derosa, G; Fogari, R; Maffioli, P; Mugellini, A; Preti, P; Zoppi, A | 1 |
Chaudhari, AJ; Gorle, AP; Jain, PS; Patel, MK; Surana, SJ | 1 |
Anisiuba, BC; Ba, SA; Boombhi, HJ; Ezeala-Adikaibe, B; Ijoma, CK; Kamdem, MM; Kaptue, J; Kingue, S; Kolo, PM; Lemogoum, D; M'Buyamba-Kabangu, JR; Ndiaye, MB; Odili, AN; Omotoso, BA; Shu, EN; Staessen, JA; Thijs, L; Ulasi, II | 1 |
Barrios, V; de la Sierra, A | 1 |
Eguchi, K; Fukutomi, M; Hoshide, S; Kabutoya, T; Kario, K; Watanabe, T | 1 |
Maa, JF; Neutel, J; Shojaee, A | 1 |
Chen, JF; Hung, YJ; Lee, IT; Lee, WJ; Sheu, WH; Wang, CY | 2 |
Morris, JK; Wald, DS; Wald, NJ | 1 |
Fang, H; Konis, G; Lacourcière, Y; Severin, T; Taddei, S; Zhang, J | 1 |
Maa, JF; Punzi, H; Shojaee, A | 1 |
Ammentorp, B; Christian Rump, L; Laeis, P; Volpe, M | 1 |
Brunner, HR; Hua, TA; Jia, Y; Julius, S; Kjeldsen, SE; Mancia, G; McInnes, GT; Schork, A; Weber, MA; Zanchetti, A; Zappe, DH | 1 |
Huan, Y; Townsend, R | 1 |
Hsueh, WA; Maa, JF; Neutel, JM; Shojaee, A | 1 |
Chrysant, SG; Fernandez, V; Heyrman, R; Izzo, JL; Kereiakes, DJ; Lee, J; Littlejohn, T; Melino, M | 1 |
Paneni, F; Passerini, J; Tocci, G; Volpe, M | 1 |
Garcia-Puig, J; Koenig, W; Murray, AV; Patel, S; Uddin, A; Zhang, J | 1 |
Bakris, GL; Dahlof, B; Jamerson, K; Pitt, B; Velazquez, EJ; Weber, MA; Weir, MR; Zappe, D; Zhang, Y | 1 |
Maa, JF; Nesbitt, SD; Shojaee, A; Weir, MR | 1 |
Kothari, C; Mehta, P; Sharma, M; Sherikar, O | 1 |
de la Sierra, A; Volpe, M | 1 |
Eguchi, K; Fukutomi, M; Hoshide, S; Kario, K; Watanabe, T | 1 |
Dussouil, AS; Gaudy-Marqueste, C; Grob, JJ; Mallet, S; Monestier, S; Richard, MA; Tasei, AM | 1 |
Biswas, E; Choudhury, H; Ghosh, B; Gorain, B; Halder, D; Pal, TK; Sarkar, AK; Sarkar, P | 1 |
Ayaori, M; Higashi, K; Hosoai, H; Ikewaki, K; Kijima, F; Nakamura, H; Nashida, Y; Nishiwaki, M; Shige, H; Shimizu, S; Yamashita, T; Yokoyama, M | 1 |
Hasebe, N; Kikuchi, K; Koyama, S; Maruyama, J; Morimoto, H; Morita, K; Saijo, Y; Sano, H; Sasagawa, Y; Sato, N; Sumitomo, K; Takehara, N; Takeuchi, T | 2 |
Dada, FL; Isah, AO; Iyalomhe, GB; Iyalomhe, OO; Iyalomhe, SI; Omogbai, EK | 1 |
Freytag, S; Hagendorff, A; Klebs, S; Müller, A | 1 |
Fernandez, V; Heyrman, R; Izzo, JL; Lee, J; Lewin, AJ; Melino, M | 1 |
Bakris, G; Briasoulis, A; Dahlof, B; Hester, A; Hua, T; Jamerson, K; Kelly, RY; Pitt, B; Weber, MA; Zappe, D | 1 |
Akinpelu, AO; Maruf, FA; Salako, BL | 1 |
Aksenova, AV; Chazova, IE; Elfimova, EM; Galitsin, PV; Litvin, AY; Rogoza, AN; Sukmarova, ZN | 1 |
Agarwal, R; Weir, MR | 1 |
Calhoun, DA; Crikelair, N; Glazer, RD; Jia, Y; Lacourcière, Y | 1 |
Darwish, HW; El-Zeany, BA; Hassan, SA; Salem, MY | 2 |
Anisiuba, BC; Ba, SA; Boombhi, HJ; Ezeala-Adikaibe, B; Ijoma, CK; Jacobs, L; Kaptue, J; Kingue, S; Kolo, PM; Lemogoum, D; M'Buyamba-Kabangu, JR; Mipinda, JB; Ndiaye, MB; Odili, A; Omotoso, BA; Osakwe, CE; Staessen, JA; Thijs, L; Ulasi, II | 1 |
Maa, JF; Shojaee, A; Weir, MR | 1 |
Abrams, DC; Bacchetta, M; Bouchard, NC; Brodie, D; Burkart, KM; Dzierba, AL; Weinberg, RL | 1 |
Fernandez, V; Heyrman, R; Lee, J; Melino, M; Oparil, S; Roth, EM | 1 |
Gnudi, L; Hill, B; Karalliedde, J; Maltese, G; Viberti, G | 1 |
Soucek, M; Spinar, J; Vitovec, J | 1 |
Ruilope, LM; Segura, J | 1 |
Dobrokhod, AS; Kushnir, SM; Radchenko, GD; Sirenko, YM; Torbas, OO | 1 |
Handler, J | 1 |
Cao, C; Dong, X; Gao, D; Liu, Y; Niu, X; Song, A; Wei, J; Yan, R | 1 |
D'Angelo, A; Derosa, G; Fogari, R; Lazzari, P; Mugellini, A; Zoppi, A | 1 |
Chazova, IE; Martyniuk, TV | 1 |
Guggilla, R; Jan, S; Kallakuri, S; Maulik, PK; Naik, N; Patel, A; Prabhakaran, D; Rodgers, A; Salam, A; Selak, V; Singh, K; Thom, S; Webster, R | 1 |
Agaliotis, GD; Andreadis, EA; Angelopoulos, ET; Kolyvas, GN; Mousoulis, CG; Mousoulis, GP | 1 |
Bakris, G; Byrd, JB; Jamerson, K | 1 |
Punzi, HA | 1 |
de la Sierra, A; Kreutz, R; Laurent, S; Manolis, AJ; Volpe, M | 1 |
Diab, SS; Merey, HA; Moustafa, AA; Ramadan, NK | 1 |
Abid, R; Afzal, J; Iktidar, S; Khan, W; Kumar, K; Maheshwary, N; Moin, N; Qadir, M; Sakrani, J; Siddiqi, A | 1 |
Belal, F; Ebeid, WM; El-Enany, N; Patonay, G; Salim, MM; Walash, M | 1 |
Bosch, J; Copland, I; Dagenais, G; Dans, A; Diaz, R; Joseph, P; Jung, H; Liu, L; Mancia, G; O'Donnell, M; Pfeffer, M; Pogue, J; Teo, KK; Yusuf, S | 1 |
Chrysant, SG; Fernandez, V; Izzo, JL; Kereiakes, DJ; Lee, J; Lewin, AJ; Melino, M; Oparil, S | 1 |
Bramlage, P; Fronk, EM; Ketelhut, R; Schmieder, RE; Smolnik, R; Wolf, WP; Zemmrich, C | 1 |
Ammentorp, B; de la Sierra, A; Laeis, P; Volpe, M | 1 |
Mannemala, SS; Nagarajan, JS | 1 |
Bidani, AK; Griffin, KA; Litbarg, N; Picken, M; Polichnowski, A; Venkatachalam, MA | 1 |
Beil, M; Danhof, M; Fu, F; Luttringer, O; Ploeger, BA; Rigel, DF; Snelder, N; Stanski, DR | 1 |
Assaad-Khalil, SH; Cho, B; Kitchlew, AR; Knap, D; Najem, R; Shete, A; Sison, J; Ueng, KC | 1 |
Ando, K; Fujita, T; Isshiki, M; Kashihara, N; Nakanishi, T; Nangaku, M; Nishizawa, Y; Nitta, K; Rakugi, H; Shimosawa, T; Takahashi, K; Tomita, K; Yokoyama, H | 1 |
O'Brien, E | 1 |
Ahn, T; Bae, JH; Han, KR; Hyon, MS; Kim, WH; Kim, YK; Lee, SU; Lim, DS; Park, HK; Suh, SY | 1 |
Kobalava, ZhD; Kotovskaia, IuV; Kravtsova, OA; Lobzhanidze, TV | 1 |
Baser, O; Frech-Tamas, F; Marrett, E; Xie, L | 1 |
Ammentorp, B; de la Sierra, A; Kreutz, R; Laeis, P | 1 |
Azuma, K; Fujita, KP; Nishida, C; Numaguchi, H; Rakugi, H; Shimada, K; Shirakawa, M; Tsuchihashi, T; Yamaguchi, H | 2 |
Nagata, M; Takase, B | 1 |
Angeloni, E; Lombardo, P; Pirelli, M; Refice, S; Vitaterna, A | 1 |
Asp, J; Dahlöf, B; Jamerson, KA; Jia, Y; Kjeldsen, SE; Östergren, J; Skoglund, PH; Svensson, P; Weber, MA; Zappe, DH | 1 |
Bramlage, P; Fronk, EM; Schmieder, RE; Smolnik, R; Sutton, G; Wolf, WP | 1 |
Ebeid, WM; El-Bagary, RI; El-Zaher, AA; Elkady, EF; Patonay, G | 1 |
Boerwinkle, E; Chapman, AB; Cooper-DeHoff, RM; Donner, KM; Frau, F; Glorioso, N; Glorioso, V; Gong, Y; Gums, JG; Hiltunen, TP; Johnson, JA; Kontula, KK; Ripatti, S; Saarela, J; Salvi, E; Sarin, AP; Turner, ST; Zaninello, R | 1 |
Hegazy, MA; Lotfy, HM; Mohamed, EH; Mowaka, S | 2 |
Assaad-Khalil, SH; Cho, B; DiTommaso, S; Kitchlew, AR; Najem, R; Shete, A; Sison, J; Ueng, KC | 1 |
Hayashi, M; Iino, Y; Kawamura, T; Kuwahara, M; Nangaku, M; Uchida, S | 1 |
Schlimpert, V | 1 |
Coufal, P; Janečková, L; Jedlička, A; Vojta, J | 1 |
Bedzaĭ, AO; Prots'ko, VV; Slaba, NA; Solomennchuk, TM | 1 |
Ahn, Y; Bae, JH; Jung, HW; Kang, DH; Kim, CH; Kim, KI; Park, CG | 1 |
Brazier, JE; Guest, JF; Haag, U; Marques da Silva, P; Soro, M | 1 |
Hubert, M | 1 |
Arora, A; Jain, S; Khuller, GK; Malhotra, S; Shafiq, N; Sharma, S | 1 |
Ammentorp, B; Laeis, P; Rump, LC; Scholze, J | 1 |
El-Zeany, BA; Elzanfaly, ES; Hassan, SA; Salem, MY | 2 |
Ebeid, W; El-Bagary, R; Elkady, E; Elzahr, A; Patonay, G; Salim, M | 1 |
Anraku, Y; Inami, S; Inoue, T; Kato, T; Kikegawa, Y; Nakamoto, A; Node, K; Suzuki, A; Toyoda, S; Tsukada, K | 1 |
Chen, W; Kahler, KH; Machnicki, G; Ong, SH; Wei, ZJ | 1 |
Balakhonova, T; Boytsov, S; Deev, A; Kolos, I; Shariya, M; Skrypnik, D; Troitskiy, A; Tvorogova, T | 1 |
Lamie, NT; Mohamed, HM | 2 |
Chung, WB; Hong, TJ; Kim, BS; Kim, CJ; Oh, BH; Park, CG; Sohn, IS | 1 |
Hirata, K; Ishida, T; Kondo, K; Mori, K; Toh, R; Yasuda, T | 1 |
Ishii, K; Ito, H; Iwakura, K; Kihara, H; Toh, N; Watanabe, H; Yoshikawa, J | 1 |
Argyropoulou, MI; Christopoulou, F; Elisaf, M; Kosta, P; Rizos, EC | 1 |
Luteijn, JM; Morris, JK; Oppenheimer, P; Taylor, D; Wald, NJ | 1 |
Akinpelu, AO; Akinyemi, JO; Maruf, FA; Salako, BL | 1 |
Abdelhameed, AS; Bakheit, AH; Darwish, HW | 1 |
Ahmed, MS; El-Zaher, AA; Mahrouse, MA; Moussa, BA | 1 |
Greeley, M; Hsiao, HL; Langenickel, TH; Pal, P; Rajman, I; Rebello, S; Roberts, J; Sunkara, G; Zhou, W | 1 |
Cui, WY; Long, CL; Wang, H; Wang, RH; Zhang, YF; Zhong, ML; Zhou, HM | 1 |
Bäurle, A | 1 |
Alföldi, S; Farsang, C; Ferenci, T; Simonyi, G | 1 |
Higaki, J; Ikeda, H; Komuro, I; Kuroki, D; Nishimura, S; Ogihara, T; Shiki, K; Taniguchi, A; Ugai, H | 1 |
Azizi, M; Bergerot, D; Blanchard, A; Bobrie, G; Courand, PY; Dubourg, J; Forni, V; Frank, M; Menard, J; Mendes, M | 1 |
Higaki, J; Ikeda, H; Komuro, I; Kuroki, D; Lee, G; Nishimura, S; Ogihara, T; Shiki, K; Taniguchi, A | 1 |
Dimitriadis, K; Mani, I; Mantzouranis, E; Tousoulis, D; Tsioufis, C; Tsioufis, K | 1 |
Duran-Salgado, MB; Elizalde-Barrera, CI; Garro-Almendaro, AK; Rubio-Guerra, AF; Suarez-Cuenca, JA | 1 |
Agarwal, I; Ferket, BS; Fleischmann, KE; Hunink, MG; Khanji, M; Petersen, SE | 1 |
Atkins, E; Bennett, A; Burke, M; Chalmers, J; Chou, M; Chow, CK; Dehbi, HM; Hillis, G; Hilmer, S; Krum, H; Neal, B; Nelson, M; Patel, A; Peiris, D; Reid, CM; Rodgers, A; Rogers, K; Salam, A; Thakkar, J; Thom, S; Usherwood, T; Vo, K; Webster, R; Woodward, M | 1 |
Kar, SK; Srivastava, A | 1 |
Douros, A; Kreutz, R; Scholze, J | 1 |
Agu, PU; Aneke, EI; Azubike, NC; Eze, AA; Nwachukwu, DC; Nwachukwu, NZ; Obika, LF; Okoye, OI | 1 |
Brown, MJ; Caulfield, M; Cruickshank, JK; Ford, I; MacDonald, TM; Mackenzie, IS; McCann, GP; McInnes, G; Morant, S; Padmanabhan, S; Salsbury, J; Sever, P; Webb, DJ; Williams, B | 1 |
Nishiyama, Y; Rakugi, H; Sano, Y; Shimizu, K; Umeda, Y | 1 |
Kinugawa, Y; Nishiyama, Y; Rakugi, H; Sano, Y; Shimizu, K; Terashio, S | 1 |
Ahn, JC; Ahn, JH; Ahn, YK; Cha, DH; Chae, IH; Cho, DK; Cho, SK; Choi, YJ; Hong, SJ; Hong, TJ; Hyon, MS; Jang, JY; Jeon, DW; Jeong, JO; Kim, BS; Kim, HS; Kim, SH; Nam, CW; Oh, YS; Park, SH; Rha, SW; Song, JM; Sung, KC; Won, KH; Yang, TH; Yoo, BS; Yoo, KD; Yoon, YW | 1 |
Bakris, G; Brook, RD; Dahlöf, B; Hau, T; Jamerson, KA; Kaciroti, N; Pitt, B; Velazquez, E; Weber, M; Zappe, DH | 1 |
Aje, A; Badri, M; Barasa, F; Damasceno, A; Dzudie, A; Francis, V; Jones, E; Kana, SS; Kramer, N; Mayosi, BM; Mntla, P; Mondo, C; Ogah, O; Ogola, EN; Ogunbanjo, G; Ojji, DB; Okpechi, I; Poulter, N; Sani, MU; Shedul, G; Sliwa, K; Smythe, W | 1 |
Ayyagari, R; Chen, S; Cheng, D; Huang, XY; Wu, EQ; Xie, J | 1 |
Břicháč, J; Douša, M; Gibala, P; Kalášek, S; Kalužíková, A; Štefko, M; Tkadlecová, M | 1 |
Ekman, I; Lind, L; Lytsy, P; Marttala, K; Nowrouzi, S; Öhagen, P; Östlund, O; Sundström, J | 1 |
Jeon, I; Kim, E; Lee, HA; Lee, S; Rhee, SJ; Song, IS; Yu, KS | 1 |
Blaich, C; Hoffmann, F; Johannsen, JO; Müller, C; Reuter, H; Streichert, T; Wiesen, MHJ | 1 |
Benjeddou, M; Dludla, P; February, F; Johnson, R; Louw, J; Mabhida, S | 1 |
Bell, CS; Green, C; Molony, D; Pedroza, C; Samuel, JP; Samuels, J; Tyson, JE | 1 |
Badri, M; Barasa, F; Cornelius, V; Damasceno, A; Dzudie, A; Francis, V; Jones, E; Kramer, N; Mayosi, B; Mondo, C; Ogah, O; Ogola, E; Ojji, DB; Okpechi, IG; Poulter, N; Rayner, B; Sani, MU; Shedul, G; Shedul, GL; Sliwa, K; Smythe, W | 1 |
Bachmann, HS; Besser, M; Severing, AL; Stuermer, EK; Terberger, N | 1 |
Ahn, YK; Chae, SC; Cho, EJ; Cho, MC; Choi, DJ; Chung, WJ; Ha, JW; Hong, SJ; Hong, TJ; Kim, CJ; Kim, SK; Kim, YJ; Lee, HY; Park, CG; Park, S; Shin, J; Sohn, IS; Sung, KC; Yoo, BS; Youn, HJ | 2 |
Habara, M; Haraguchi, T; Ikezaki, H; Kojima, H; Nakamura, S; Uchida, T; Yoshida, M | 1 |
Brown, K; Donato, A | 1 |
Chokalingam, K; Dhawan, S; Hiremath, JS; Mathan, G; Reddy, PNC; Sharma, A; Toppo, A | 1 |
Hebibovic, S; Jatic, Z; Rustempasic, E; Skopljak, A; Sukalo, A; Valjevac, A | 1 |
Blot, WJ; Gonzales, H; Miller, R; Muñoz, D; Munro, H; Pappalardo, S; Reynolds, C; Song, W; Tousey, P; Uzoije, P; Walkley, D; Wang, TJ; White, C | 1 |
Jeon, JY; Kim, MG; Moon, SJ; Yu, KS | 1 |
Onakpoya, I | 1 |
Agabiti-Rosei, C; De Ciuceis, C; Paini, A; Rizzoni, D; Salvetti, M | 1 |
Bianco, HT; Ferreira, CES; Figueiredo Neto, AM; Fonseca, FAH; França, CN; Izar, MCO; Kato, JT; Massunaga, ND; Póvoa, RMS | 1 |
Ahn, MS; Ahn, SG; Choi, E; Hong, KS; Kim, JY; Lee, JW; Lee, SH; Park, SM; Ryu, DR; Son, JW; Yoo, BS; Yoon, J; Youn, YJ | 1 |
Bhandari, RK; Bhatia, A; Kaur, N; Malhotra, S; Pandey, AK; Rather, IIG; Shafiq, N; Sharma, S | 1 |
Park, SJ; Rhee, SJ | 1 |
Abdul, A; Pathan, MAAK; Raut, S; Shaikh, JSA | 1 |
Bots, ML; Groenland, EH; Spiering, W; van der Elst, KCM; van Kleef, MEAM; Visseren, FLJ | 1 |
Abousalih, FZ; Azougagh, M; Benchekroun, YH; Bennani, I; Bouatia, M; El Karbane, M; Saffaj, T | 1 |
Ahn, KT; Cho, BR; Kim, BJ; Kim, DK; Lee, SY; Lee, WS; Park, JI; Sung, J | 1 |
Attala, K; Elsonbaty, A | 1 |
Chan, JYW; Cheung, DWS; Fung, KP; Ko, ECH; Koon, JCM; Lau, VKM; Wat, ECL; Waye, MMY; Wong, PH; Yau, KC | 1 |
Katakam, P; Katari, NK; Marisetti, VM; Siddhani, VK | 1 |
Patel, A; Prajapati, PB; Shah, SA | 1 |
Altaf, RM; Iqbal, MS; Ishfaq, H; Khan, J; Khan, SU; Pervaiz, A; Shah, PA; Syed, HK; Zaidi, HA | 1 |
Agrawal, S; Anand, J; Bachani, D; Doshi, M; Gaikwad, VB; Halder, SK; Kinholkar, B; Kumar, DA; Kumbhar, A; Mathur, R; Mehta, S; Sarkar, G; Sharma, A | 1 |
Abdullakutty, J; Abhyankar, M; Dalal, J; Das, MK; Fulwani, M; Guha, S; Gupta, R; Kahali, D; Mohan, JC; Mohanan, PP; Nair, T; Narasimhan, C; Ram, CVS; Ray, S; Revankar, S; Roy, DG | 1 |
Aje, A; Albertino, D; Barasa, F; Dzudie, A; Francis, V; Hickman, N; Ingabire, PM; Jones, ESW; Mondo, C; Ogah, OS; Ogola, E; Ojji, DB; Rayner, B; Sani, M; Shahiemah, P; Shedul, G; Shedul, GL; Sliwa, K; Smythe, W; Stewart, S | 1 |
Dragoi, EN; Erk, N; Joo, SW; Lotfy, HM; Mehmandoust, M; Tiris, G; Vasseghian, Y | 1 |
Abdelkawy, M; El-Hanboushy, S; Fayez, YM; Lotfy, HM; Marzouk, HM | 1 |
Bhargava, B; Durgad, K; Gupta, S; Kaur, P; Kunwar, A; Sharma, M | 1 |
Barasa, F; Cornelius, V; Damasceno, A; Dzudie, A; Francis, V; Hickman, N; Ingabire, PM; Jones, E; Mondo, C; Ogah, O; Ogola, E; Ojji, DB; Pandie, S; Partington, G; Poulter, N; Rayner, B; Sani, MU; Shedul, G; Shedul, GL; Sliwa, K; Smythe, W | 1 |
Burnier, M; Redon, J; Volpe, M | 1 |
Böhm, M; Götzinger, F; Hohl, M; Hübner, U; Lauder, L; Lehnert, U; Mahfoud, F; Meyer, MR; Schneider, C; Sevimli, Ö; Tokcan, M; Wagmann, L | 1 |
Hagström, E; Held, C; Lind, L; Lytsy, P; Marttala, K; Neal, B; Nowrouzi, S; Östlund, O; Sundström, J | 1 |
Liang, H; Tang, T; Xie, M | 1 |
Hong, JH; Hyun, D; Kim, GH; Kim, HL; Kim, W; Lim, S; Min, KW; Oh, J; Park, SD; Shin, J | 1 |
25 review(s) available for amlodipine and hydrochlorothiazide
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
A review of the efficacy of fixed-dose combinations olmesartan medoxomil/hydrochlorothiazide and amlodipine besylate/benazepril in factorial design studies.
Topics: Amlodipine; Antihypertensive Agents; Benzazepines; Blood Pressure; Drug Therapy, Combination; Factor Analysis, Statistical; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Olmesartan Medoxomil; Randomized Controlled Trials as Topic; Tetrazoles | 2006 |
Combination therapy with renin-angiotensin system blockers: will amlodipine replace hydrochlorothiazide?
Topics: Amlodipine; Antihypertensive Agents; Calcium Channel Blockers; Diuretics; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Randomized Controlled Trials as Topic; Renin-Angiotensin System | 2007 |
Comparison of angiotensin II type 1 receptor antagonists in the treatment of essential hypertension.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Calcium Channel Blockers; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension | 2008 |
Valsartan-amlodipine-hydrochlorothiazide: the definitive fixed combination?
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Diuretics; Drug Combinations; Humans; Hydrochlorothiazide; Hypertension; Medication Adherence; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2010 |
Olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide triple combination for hypertension.
Topics: Amlodipine; Antihypertensive Agents; Drug Combinations; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Olmesartan Medoxomil; Tetrazoles | 2011 |
Olmesartan medoxomil/amlodipine/hydrochlorothiazide: fixed-dose combination in hypertension.
Topics: Amlodipine; Antihypertensive Agents; Drug Combinations; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Tetrazoles | 2011 |
In brief: Another three-drug combination for hypertension.
Topics: Amides; Amlodipine; Animals; Drug Approval; Drug Combinations; Fumarates; Humans; Hydrochlorothiazide; Hypertension; Tablets; United States | 2011 |
Triple-drug, fixed-dose combinations for the treatment of hypertension: focus on olmesartan/amlodipine/hydrochlorothiazide combination.
Topics: Amlodipine; Antihypertensive Agents; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Olmesartan Medoxomil; Tetrazoles | 2011 |
Angiotensin II receptor blocker combinations: from guidelines to clinical practice.
Topics: Amlodipine; Angiotensin Receptor Antagonists; Antineoplastic Agents; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Medication Adherence; Practice Guidelines as Topic; Tetrazoles | 2012 |
Single-pill triple-combination therapy: an alternative to multiple-drug treatment of hypertension.
Topics: Amides; Amlodipine; Antihypertensive Agents; Drug Combinations; Drug Design; Fumarates; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Medication Adherence; Olmesartan Medoxomil; Practice Guidelines as Topic; Practice Patterns, Physicians'; Tetrazoles; Valine; Valsartan | 2011 |
Aliskiren, amlodipine and hydrochlorothiazide triple combination for hypertension.
Topics: Amides; Amlodipine; Antihypertensive Agents; Blood Pressure; Drug Therapy, Combination; Fumarates; Humans; Hydrochlorothiazide; Hypertension; Treatment Outcome | 2012 |
Blood pressure control with angiotensin receptor blocker-based three-drug combinations: key trials.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Diuretics; Drug Combinations; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Olmesartan Medoxomil; Randomized Controlled Trials as Topic; Tetrazoles; Valine; Valsartan | 2012 |
The single pill triple combination of aliskiren, amlodipine, and hydrochlorothiazide in the treatment of hypertension.
Topics: Amides; Amlodipine; Antihypertensive Agents; Drug Combinations; Fumarates; Humans; Hydrochlorothiazide; Hypertension; Treatment Outcome | 2012 |
Triple combination therapy to improve blood pressure control: experience with olmesartan-amlodipine-hydrochlorothiazide therapy.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Calcium Channel Blockers; Clinical Trials as Topic; Diuretics; Drug Therapy, Combination; Evidence-Based Medicine; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Tetrazoles | 2012 |
Blood pressure response with fixed-dose combination therapy: comparing hydrochlorothiazide with amlodipine through individual-level meta-analysis.
Topics: Aged; Amlodipine; Angiotensin Receptor Antagonists; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Body Mass Index; Calcium Channel Blockers; Diabetes Complications; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Imidazoles; Male; Middle Aged; Multivariate Analysis; Olmesartan Medoxomil; Sex Factors; Tetrazoles | 2013 |
Effectiveness of the fixed-dose combination of olmesartan/amlodipine/hydrochlorothiazide for the treatment of hypertension in patients stratified by age, race and diabetes, CKD and chronic CVD.
Topics: Age Factors; Amlodipine; Cardiovascular Diseases; Diabetes Complications; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Renal Insufficiency, Chronic; Tetrazoles | 2013 |
A review of the benefits of early treatment initiation with single-pill combinations of telmisartan with amlodipine or hydrochlorothiazide.
Topics: Administration, Oral; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Calcium Channel Blockers; Diuretics; Drug Combinations; Humans; Hydrochlorothiazide; Hypertension; Tablets; Telmisartan; Time Factors; Treatment Outcome | 2013 |
Aliskiren/amlodipine vs. aliskiren/hydrochlorothiazide in hypertension: indirect meta-analysis of trials comparing the two combinations vs. monotherapy.
Topics: Amides; Amlodipine; Antihypertensive Agents; Blood Pressure; Drug Therapy, Combination; Female; Fumarates; Humans; Hydrochlorothiazide; Hypertension; Male; Renin | 2014 |
The contribution of the ACCOMPLISH trial to the treatment of stage 2 hypertension.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Calcium Channel Blockers; Diuretics; Drug Combinations; Humans; Hydrochlorothiazide; Hypertension; Practice Guidelines as Topic; Randomized Controlled Trials as Topic | 2014 |
Quarter-dose quadruple combination therapy for initial treatment of hypertension: placebo-controlled, crossover, randomised trial and systematic review.
Topics: Administration, Oral; Amlodipine; Antihypertensive Agents; Atenolol; Biphenyl Compounds; Blood Pressure; Cross-Over Studies; Double-Blind Method; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Irbesartan; Male; Medication Adherence; Middle Aged; Tetrazoles; Treatment Outcome | 2017 |
Pharmacogenomics of amlodipine and hydrochlorothiazide therapy and the quest for improved control of hypertension: a mini review.
Topics: Adult; Amlodipine; Antihypertensive Agents; Female; Genome-Wide Association Study; Genome, Human; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Pharmacogenomic Variants; Polymorphism, Single Nucleotide | 2019 |
Plasma Trough Concentrations of Antihypertensive Drugs for the Assessment of Treatment Adherence: A Meta-Analysis.
Topics: Amlodipine; Antihypertensive Agents; Humans; Hydrochlorothiazide; Hypertension; Treatment Adherence and Compliance; Valsartan | 2021 |
Single-Pill Combination with Three Antihypertensive Agents to Improve Blood Pressure Control in Hypertension: Focus on Olmesartan-Based Combinations.
Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Leukemia, Myeloid, Acute; Olmesartan Medoxomil | 2023 |
Efficacy of single-pill combination in uncontrolled essential hypertension: A systematic review and network meta-analysis.
Topics: Amlodipine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Drug Therapy, Combination; Essential Hypertension; Humans; Hydrochlorothiazide; Hypertension; Irbesartan; Losartan; Network Meta-Analysis; Telmisartan; Tetrazoles; Valine; Valsartan | 2023 |
202 trial(s) available for amlodipine and hydrochlorothiazide
Article | Year |
---|---|
Long-term open evaluation of amlodipine versus hydrochlorothiazide in patients with essential hypertension.
Topics: Adolescent; Adult; Aged; Amlodipine; Blood Pressure; Calcium Channel Blockers; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Nifedipine; Pulse; Random Allocation | 1988 |
Double-blind comparison of amlodipine and hydrochlorothiazide in patients with mild to moderate hypertension.
Topics: Adolescent; Adult; Aged; Amlodipine; Blood Pressure; Calcium Channel Blockers; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Nifedipine; Random Allocation; Time Factors | 1988 |
Safety and efficacy of amlodipine added to hydrochlorothiazide therapy in essential hypertension.
Topics: Adult; Aged; Amlodipine; Blood Pressure; Calcium Channel Blockers; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Multicenter Studies as Topic; Nifedipine; Random Allocation | 1989 |
Antihypertensive effectiveness of amlodipine in combination with hydrochlorothiazide.
Topics: Alanine Transaminase; Amlodipine; Aspartate Aminotransferases; Calcium Channel Blockers; Cholesterol, HDL; Cholesterol, LDL; Double-Blind Method; Drug Therapy, Combination; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Nifedipine; Supination | 1989 |
The safety of amlodipine.
Topics: Adrenergic beta-Antagonists; Aged; Amlodipine; Calcium Channel Blockers; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Edema; Fatigue; Flushing; Humans; Hydrochlorothiazide; Hypertension; Middle Aged; Nifedipine | 1989 |
Low-dose drug combination therapy: an alternative first-line approach to hypertension treatment.
Topics: Adult; Aged; Amlodipine; Analysis of Variance; Bisoprolol; Blood Pressure; Double-Blind Method; Drug Therapy, Combination; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Quality of Life; United States | 1995 |
The efficacy and tolerability of amlodipine and hydrochlorothiazide in Nigerians with essential hypertension.
Topics: Amlodipine; Blood Pressure; Drug Tolerance; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Hypokalemia; Male; Middle Aged; Nigeria; Posture; Potassium; Safety; Single-Blind Method; Supine Position; Urea | 1995 |
Effects of different antihypertensive drugs on plasma fibrinogen in hypertensive patients.
Topics: Adolescent; Adult; Aged; Amlodipine; Antihypertensive Agents; Atenolol; Blood Glucose; Blood Pressure; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Creatinine; Fibrinogen; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Lisinopril; Male; Middle Aged; Potassium; Triglycerides; Uric Acid | 1995 |
Changes in lipid and lipoprotein values during a cross-over treatment of doxazosin, moduretic and amlodipine in hypertensive patients.
Topics: Adult; Aged; Amiloride; Amlodipine; Antihypertensive Agents; Cross-Over Studies; Double-Blind Method; Doxazosin; Drug Combinations; Humans; Hydrochlorothiazide; Hypertension; Lipids; Lipoproteins; Middle Aged | 1994 |
Double-blind comparison of amlodipine and hydrochlorothiazide in patients with mild to moderate hypertension.
Topics: Adolescent; Adult; Aged; Amlodipine; Atenolol; Blood Pressure; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Double-Blind Method; Drug Combinations; Electrocardiography; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Pulse; Safety; Single-Blind Method; Triglycerides | 1994 |
Long-term open evaluation of amlodipine vs hydrochlorothiazide in patients with essential hypertension.
Topics: Adolescent; Adult; Aged; Amlodipine; Blood Pressure; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male | 1993 |
APTH--a trial on ambulatory blood pressure monitoring and treatment of hypertension: objectives and protocol.
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure Determination; Blood Pressure Monitors; Dipeptides; Humans; Hydrochlorothiazide; Hypertension; Hypertrophy, Left Ventricular; Lisinopril; Research Design; Time Factors | 1993 |
Relationship between body mass index (BMI) and changes in plasma total and HDL-cholesterol levels during treatment of hypertension in African patients.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Black People; Body Mass Index; Cholesterol; Cholesterol, HDL; Doxazosin; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Nigeria | 1995 |
'Hypertension resistant to two-drug treatment' is a useful criterion to select patients for angiography: the 'Dutch Renal Artery Stenosis Intervention Cooperative' (DRASTIC) study.
Topics: Adolescent; Adult; Aged; Amlodipine; Angiography; Antihypertensive Agents; Atenolol; Drug Resistance, Multiple; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Patient Selection; Radionuclide Imaging; Renal Artery Obstruction | 1996 |
Blood pressure and blood glucose levels during a cross-over treatment of doxazosin, moduretic and amlodipine in hypertensive patients.
Topics: Adult; Aged; Amiloride; Amlodipine; Antihypertensive Agents; Blood Glucose; Blood Pressure; Cross-Over Studies; Doxazosin; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Treatment Outcome | 1996 |
Biochemical changes during a cross-over treatment of doxazosin, moduretic and amlodipine in hypertensive patients.
Topics: Adult; Aged; Amiloride; Amlodipine; Antihypertensive Agents; Blood Proteins; Calcium; Creatinine; Cross-Over Studies; Double-Blind Method; Doxazosin; Drug Combinations; Electrolytes; Humans; Hydrochlorothiazide; Hypertension; Middle Aged | 1996 |
Antihypertensive effects of amlodipine and hydrochlorothiazide in elderly patients with ambulatory hypertension.
Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Drug Therapy, Combination; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Male; Single-Blind Method | 1995 |
Physical performance is preserved after regression of left ventricular hypertrophy.
Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Double-Blind Method; Drug Therapy, Combination; Exercise; Female; Humans; Hydrochlorothiazide; Hypertension; Hypertrophy, Left Ventricular; Male; Ventricular Function, Left | 1997 |
Efficacy of low-dose combination of bisoprolol/hydrochlorothiazide compared with amlodipine and enalapril in men and women with essential hypertension.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Bisoprolol; Blood Pressure; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged | 1998 |
Effects of losartan titrated to losartan/hydrochlorothiazide and amlodipine on blood pressure and peripheral capillary microcirculation in patients with mild-to-moderate hypertension.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Blood Flow Velocity; Blood Pressure; Capillaries; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Microcirculation; Middle Aged | 1998 |
Low-dose combination therapy as first-line hypertension treatment for blacks and nonblacks.
Topics: Aged; Amlodipine; Analysis of Variance; Antihypertensive Agents; Bisoprolol; Black People; Chi-Square Distribution; Double-Blind Method; Drug Therapy, Combination; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged | 1999 |
Low-dose combination treatment for hypertension versus single-drug treatment-bisoprolol/hydrochlorothiazide versus amlodipine, enalapril, and placebo: combined analysis of comparative studies.
Topics: Amlodipine; Bisoprolol; Double-Blind Method; Drug Therapy, Combination; Enalapril; Humans; Hydrochlorothiazide; Hypertension | 1998 |
Effects of losartan titrated to Losartan/Hydrochlorothiazide and amlodipine on left ventricular mass in patients with mild-to-moderate hypertension. A double-blind randomized controlled study.
Topics: Adult; Aged; Amlodipine; Angiotensin Receptor Antagonists; Antihypertensive Agents; Blood Pressure; Body Mass Index; Double-Blind Method; Echocardiography; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Hypertrophy, Left Ventricular; Losartan; Male; Middle Aged; Treatment Outcome | 1999 |
Comparison of atenolol, amlodipine, enalapril, hydrochlorothiazide, and losartan for antihypertensive treatment in patients with obstructive sleep apnea.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Cross-Over Studies; Diuretics; Double-Blind Method; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Middle Aged; Single-Blind Method; Sleep Apnea, Obstructive; Sodium Chloride Symporter Inhibitors | 2000 |
Efficacy of candesartan cilexetil alone or in combination with amlodipine and hydrochlorothiazide in moderate-to-severe hypertension. UK and Israel Candesartan Investigators.
Topics: Aldosterone; Amlodipine; Analysis of Variance; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure Monitoring, Ambulatory; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Israel; Male; Middle Aged; Renin; Single-Blind Method; Tetrazoles; United Kingdom | 2000 |
Efficacy, safety, and effects on quality of life of bisoprolol/hydrochlorothiazide versus amlodipine in elderly patients with systolic hypertension.
Topics: Adrenergic beta-Antagonists; Aged; Amlodipine; Bisoprolol; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Circadian Rhythm; Diuretics; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Quality of Life; Safety; Sodium Chloride Symporter Inhibitors; Systole; Treatment Outcome | 2000 |
A comparison of indapamide SR 1.5 mg with both amlodipine 5 mg and hydrochlorothiazide 25 mg in elderly hypertensive patients: a randomized double-blind controlled study.
Topics: Aged; Aged, 80 and over; Amlodipine; Antihypertensive Agents; Double-Blind Method; Female; Humans; Hydrochlorothiazide; Hypertension; Indapamide; Male; Middle Aged | 2001 |
A multicenter, randomized double-blind study of valsartan/hydrochlorothiazide combination versus amlodipine in patients with mild to moderate hypertension.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Double-Blind Method; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Severity of Illness Index; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2001 |
Resistance to antihypertensive medication as predictor of renal artery stenosis: comparison of two drug regimens.
Topics: Adolescent; Adult; Aged; Amlodipine; Antihypertensive Agents; Atenolol; Blood Pressure; Cohort Studies; Drug Resistance; Drug Therapy, Combination; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension, Renal; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Radiography; Renal Artery; Renal Artery Obstruction | 2001 |
Trough:peak ratio and smoothness index in the evaluation of 24-h blood pressure control in hypertension: a comparative study between valsartan/hydrochlorothiazide combination and amlodipine.
Topics: Adult; Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Double-Blind Method; Drug Combinations; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Prospective Studies; Tetrazoles; Time Factors; Valine; Valsartan | 2002 |
Comparison of benazepril-amlodipine and captopril-thiazide combinations in the management of mild-to-moderate hypertension.
Topics: Administration, Oral; Aged; Amlodipine; Antihypertensive Agents; Benzazepines; Captopril; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged | 2002 |
[Arterial hypertension in elderly individuals].
Topics: Age Factors; Aged; Aged, 80 and over; Amlodipine; Antihypertensive Agents; Calcium Channel Blockers; Diuretics; Double-Blind Method; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Indapamide; Sodium Chloride Symporter Inhibitors; Time Factors | 2002 |
Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study.
Topics: Adult; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Enalapril; Eplerenone; Female; Humans; Hydrochlorothiazide; Hypertension; Hypertrophy, Left Ventricular; Magnetic Resonance Imaging; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Myocardium; Potassium; Renin-Angiotensin System; Spironolactone; Treatment Outcome | 2003 |
A randomized, double-blind, active-controlled, parallel-group comparison of valsartan and amlodipine in the treatment of isolated systolic hypertension in elderly patients: the Val-Syst study.
Topics: Aged; Aged, 80 and over; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Calcium Channel Blockers; Diuretics; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Sodium Chloride Symporter Inhibitors; Systole; Tetrazoles; Valine; Valsartan | 2003 |
Efficacy and tolerability of the combination valsartan/hydrochlorothiazide compared with amlodipine in a mild-to-moderately hypertensive Brazilian population.
Topics: Aged; Amlodipine; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Brazil; Double-Blind Method; Drug Therapy, Combination; Edema; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Racial Groups; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2003 |
Comparison of the effects on 24-h ambulatory blood pressure of valsartan and amlodipine, alone or in combination with a low-dose diuretic, in elderly patients with isolated systolic hypertension (Val-syst Study).
Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Diuretics; Drug Therapy, Combination; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Tetrazoles; Valine; Valsartan | 2004 |
Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial.
Topics: Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Cardiovascular Diseases; Diuretics; Double-Blind Method; Endpoint Determination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Risk Factors; Sodium Chloride Symporter Inhibitors; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2004 |
Rationale and design of a study comparing two fixed-dose combination regimens to reduce albuminuria in patients with type II diabetes and hypertension.
Topics: Adult; Aged; Aged, 80 and over; Albuminuria; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diuretics; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Kidney Failure, Chronic; Male; Middle Aged; Renin-Angiotensin System; Research Design; Sodium Chloride Symporter Inhibitors | 2005 |
24-hour ambulatory blood-pressure effects of valsartan and hydrochlorothiazide combinations compared with amlodipine in hypertensive patients at increased cardiovascular risk: a VAST sub-study.
Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Risk Factors; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2005 |
Evaluation of long-term efficacy and acceptability of indapamide SR in elderly hypertensive patients.
Topics: Aged; Aged, 80 and over; Amlodipine; Analysis of Variance; Antihypertensive Agents; Double-Blind Method; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Indapamide; Male; Treatment Outcome | 2005 |
Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
Topics: Age Factors; Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Cerebrovascular Disorders; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypercholesterolemia; Hypertension; Male; Middle Aged; Myocardial Infarction; Obesity; Risk Factors; Tetrazoles; Valine; Valsartan | 2005 |
A noninferiority comparison of valsartan/hydrochlorothiazide combination versus amlodipine in black hypertensives.
Topics: Adult; Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Black People; Blood Pressure; Calcium Channel Blockers; Diuretics; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Prospective Studies; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2005 |
Effects of a structured treatment algorithm on blood pressure goal rates in both stage 1 and stage 2 hypertension.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Blood Pressure; Calcium Channel Blockers; Diuretics; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Olmesartan Medoxomil; Severity of Illness Index; Tetrazoles; Treatment Outcome | 2006 |
Urinary TGF-beta1 reduction related to a decrease of systolic blood pressure in patients with type 2 diabetes and clinical diabetic nephropathy.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Blood Glucose; Blood Pressure; Captopril; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Therapy, Combination; Enalapril; Female; Follow-Up Studies; Glycated Hemoglobin; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Potassium; Propranolol; Ramipril; Transforming Growth Factor beta1 | 2006 |
Targeting hypertension with valsartan: Lessons learned from the Valsartan/HCTZ versus Amlodipine in stage II hypertensive patients (VASt) trial.
Topics: Amlodipine; C-Reactive Protein; Drug Combinations; Humans; Hydrochlorothiazide; Hypertension; Interleukin-6; Lipoproteins, LDL; Tetrazoles; Tissue Plasminogen Activator; Valine; Valsartan | 2006 |
Predictors of antihypertensive drug responses: initial data from a placebo-controlled, randomized, cross-over study with four antihypertensive drugs (The GENRES Study).
Topics: Adrenergic beta-Antagonists; Adult; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Bisoprolol; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Cross-Over Studies; Diuretics; Double-Blind Method; Drug Therapy, Combination; Finland; Genetic Variation; Genotype; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Middle Aged; Phenotype; Predictive Value of Tests; Prospective Studies; Reproducibility of Results; Time Factors; Treatment Outcome | 2007 |
Direct Renin inhibition with aliskiren in obese patients with arterial hypertension.
Topics: Administration, Oral; Adult; Aged; Amides; Amlodipine; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Diastole; Double-Blind Method; Female; Fumarates; Humans; Hydrochlorothiazide; Hypertension; Irbesartan; Male; Middle Aged; Obesity; Renin; Systole; Tetrazoles; Treatment Outcome | 2007 |
Long-term efficacy of combination therapy with losartan and low-dose hydrochlorothiazide in patients with uncontrolled hypertension.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Middle Aged; Tetrazoles; Treatment Outcome | 2007 |
Baseline characteristics in the Avoiding Cardiovascular events through Combination therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial: a hypertensive population at high cardiovascular risk.
Topics: Aged; Amlodipine; Antihypertensive Agents; Benzazepines; Body Mass Index; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Myocardial Infarction; Patient Selection; Scandinavian and Nordic Countries; Stroke; United States | 2007 |
Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Lisinopril; Male; Middle Aged; Tetrazoles; Valine; Valsartan | 2007 |
Exceptional early blood pressure control rates: the ACCOMPLISH trial.
Topics: Amlodipine; Antihypertensive Agents; Benzazepines; Blood Pressure; Double-Blind Method; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension | 2007 |
Efficacy and tolerability of candesartan cilexetil/hydrochlorothiazide and amlodipine in patients with poorly controlled mild-to-moderate essential hypertension.
Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Biphenyl Compounds; Calcium Channel Blockers; Diuretics; Double-Blind Method; Drug Therapy, Combination; Edema; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Severity of Illness Index; Tetrazoles; Treatment Outcome | 2007 |
Efficacy and safety of olmesartan medoxomil and hydrochlorothiazide compared with benazepril and amlodipine besylate.
Topics: Amlodipine; Antihypertensive Agents; Benzazepines; Blood Pressure; Diastole; Drug-Related Side Effects and Adverse Reactions; Female; Goals; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Olmesartan Medoxomil; Systole; Tetrazoles; Treatment Outcome | 2007 |
Effectiveness of add-on low-dose diuretics in combination therapy for hypertension: losartan/hydrochlorothiazide vs. candesartan/amlodipine.
Topics: Aged; Amlodipine; Antihypertensive Agents; Asian People; Benzimidazoles; Biphenyl Compounds; Diuretics; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Japan; Losartan; Male; Middle Aged; Prospective Studies; Tetrazoles; Treatment Outcome | 2007 |
Efficacy of the combination of amlodipine and valsartan in patients with hypertension uncontrolled with previous monotherapy: the Exforge in Failure after Single Therapy (EX-FAST) study.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Retreatment; Tetrazoles; Valine; Valsartan | 2008 |
Blood pressure and cardiorenal responses to antihypertensive therapy in obese women.
Topics: Adult; Amlodipine; Analysis of Variance; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Body Fat Distribution; Body Mass Index; Cilazapril; Drug Therapy, Combination; Echocardiography; Female; Humans; Hydrochlorothiazide; Hypertension; Middle Aged; Obesity; Regression Analysis; Statistics, Nonparametric; Treatment Outcome | 2008 |
Effects of different ACE inhibitor combinations on albuminuria: results of the GUARD study.
Topics: Adult; Aged; Aged, 80 and over; Albuminuria; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Blood Pressure; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diuretics; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Treatment Outcome | 2008 |
Valsartan improves arterial stiffness in type 2 diabetes independently of blood pressure lowering.
Topics: Adult; Aged; Aged, 80 and over; Albuminuria; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Arteries; Blood Pressure; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2008 |
Laboratory tests as predictors of the antihypertensive effects of amlodipine, bisoprolol, hydrochlorothiazide and losartan in men: results from the randomized, double-blind, crossover GENRES Study.
Topics: Adult; Amlodipine; Antihypertensive Agents; Bisoprolol; Blood Pressure; Calcium; Cross-Over Studies; Double-Blind Method; Forecasting; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Middle Aged; Renin; Sodium; Treatment Outcome | 2008 |
Effects of a fixed-dose ACE inhibitor-diuretic combination on ambulatory blood pressure and arterial properties in isolated systolic hypertension.
Topics: Aged; Aged, 80 and over; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Calcium Channel Blockers; Cross-Over Studies; Diuretics; Double-Blind Method; Drug Combinations; Female; Fosinopril; Humans; Hydrochlorothiazide; Hypertension; Indapamide; Male; Middle Aged; Monitoring, Ambulatory; Prospective Studies | 2008 |
Predictors of blood pressure response to intensified and fixed combination treatment of hypertension: the ACCOMPLISH study.
Topics: Aged; Amlodipine; Antihypertensive Agents; Benzazepines; Blood Pressure; Dose-Response Relationship, Drug; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Female; Finland; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Multivariate Analysis; Predictive Value of Tests; Racial Groups; Risk Assessment; Scandinavian and Nordic Countries; Treatment Outcome; United States | 2008 |
Short-term electrophysiological effects of losartan, bisoprolol, amlodipine, and hydrochlorothiazide in hypertensive men.
Topics: Action Potentials; Amlodipine; Antihypertensive Agents; Bisoprolol; Blood Pressure; Cross-Over Studies; Double-Blind Method; Electrocardiography; Electrophysiology; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Middle Aged; Time Factors; Treatment Outcome; Ventricular Function | 2009 |
Interaction between antihypertensives and NSAIDs in primary care: a controlled trial.
Topics: Acetaminophen; Aged; Amlodipine; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Blood Pressure; Drug Combinations; Drug Interactions; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Ibuprofen; Lisinopril; Male; Middle Aged; Osteoarthritis; Piroxicam; Prospective Studies | 2008 |
The diabetes subgroup baseline characteristics of the Avoiding Cardiovascular Events Through Combination Therapy in Patients Living With Systolic Hypertension (ACCOMPLISH) trial.
Topics: Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Blood Glucose; Blood Pressure; Calcium Channel Blockers; Diabetes Mellitus; Diuretics; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Prevalence; Time Factors; Treatment Outcome; United States | 2008 |
Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients.
Topics: Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Blood Pressure; Calcium Channel Blockers; Cardiovascular Diseases; Diuretics; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Kaplan-Meier Estimate; Male; Middle Aged; Risk | 2008 |
Renin-angiotensin system and alpha-adducin gene polymorphisms and their relation to responses to antihypertensive drugs: results from the GENRES study.
Topics: Adult; Amlodipine; Angiotensinogen; Antihypertensive Agents; Bisoprolol; Blood Pressure; Calmodulin-Binding Proteins; Humans; Hydrochlorothiazide; Losartan; Male; Middle Aged; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Receptor, Angiotensin, Type 1; Renin-Angiotensin System | 2009 |
Efficacy and safety of initial combination therapy with amlodipine/valsartan compared with amlodipine monotherapy in black patients with stage 2 hypertension: the EX-STAND study.
Topics: Adult; Aged; Amlodipine; Amlodipine, Valsartan Drug Combination; Antihypertensive Agents; Black People; Double-Blind Method; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Tetrazoles | 2009 |
[Is the combination of benazepril and amlodipine more effective in hypertension than the combination of benazepril and hydrochlorothiazide? Results of the ACCOMPLISH trial].
Topics: Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Blood Pressure; Calcium Channel Blockers; Diuretics; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Treatment Outcome | 2009 |
Effects of force-titrated valsartan/hydrochlorothiazide versus amlodipine/hydrochlorothiazide on ambulatory blood pressure in patients with stage 2 hypertension: the EVALUATE study.
Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Diuretics; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2009 |
Efficacy and safety of a stepped-care regimen using olmesartan medoxomil, amlodipine and hydrochlorothiazide in patients with moderate-to-severe hypertension: an open-label, long-term study.
Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Calcium Channel Blockers; Diuretics; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Olmesartan Medoxomil; Practice Guidelines as Topic; Tetrazoles | 2009 |
Effects of candesartan cilexetil on carotid remodeling in hypertensive diabetic patients: the MITEC study.
Topics: Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Calcium Channel Blockers; Carotid Artery Diseases; Carotid Artery, Common; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Disease Progression; Diuretics; Double-Blind Method; Female; France; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Tetrazoles; Time Factors; Treatment Outcome; Tunica Intima; Tunica Media; Ultrasonography | 2009 |
Triple antihypertensive therapy with amlodipine, valsartan, and hydrochlorothiazide: a randomized clinical trial.
Topics: Adult; Amlodipine; Antihypertensive Agents; Blood Pressure; Diastole; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Single-Blind Method; Systole; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2009 |
ACCOMPLISH the goal: hypertension and beyond.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Calcium Channel Blockers; Double-Blind Method; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Risk Assessment | 2009 |
Magnetic resonance imaging left ventricular mass reduction with fixed-dose angiotensin-converting enzyme inhibitor-based regimens in patients with high-risk hypertension.
Topics: Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Calcium Channel Blockers; Diuretics; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Female; Heart Ventricles; Humans; Hydrochlorothiazide; Hypertension; Hypertrophy, Left Ventricular; Magnetic Resonance Imaging; Male; Middle Aged; Risk Factors; Sex Characteristics; Treatment Outcome | 2009 |
Randomized study to compare valsartan +/- HCTZ versus amlodipine +/- HCTZ strategies to maximize blood pressure control.
Topics: Adult; Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Diuretics; Double-Blind Method; Drug Therapy, Combination; Europe; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; South America; Tetrazoles; Time Factors; Treatment Outcome; Valine; Valsartan | 2009 |
Assessing medication adherence simultaneously by electronic monitoring and pill count in patients with mild-to-moderate hypertension.
Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Determination; Double-Blind Method; Drug Packaging; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Lisinopril; Male; Medication Adherence; Middle Aged; Monitoring, Physiologic; Prospective Studies; Tablets | 2010 |
Effect of self-measurement of blood pressure on adherence to treatment in patients with mild-to-moderate hypertension.
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Double-Blind Method; Humans; Hydrochlorothiazide; Hypertension; Lisinopril; Patient Compliance; Placebos; Prospective Studies; Self Care | 2010 |
Successful treatment of hypertension accounts for improvements in markers of diastolic function - a pilot study comparing hydrochlorothiazide-based and amlodipine-based treatment strategies.
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Pilot Projects; Treatment Outcome; Ultrasonography; Ventricular Dysfunction, Left | 2009 |
Amlodipine/valsartan/hydrochlorothiazide triple combination therapy in moderate/severe hypertension: Secondary analyses evaluating efficacy and safety.
Topics: Adolescent; Adult; Amlodipine; Antihypertensive Agents; Blood Pressure; Double-Blind Method; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Tetrazoles; Valine; Valsartan | 2009 |
Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial.
Topics: Aged; Albuminuria; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Blood Pressure; Calcium Channel Blockers; Cardiovascular Diseases; Creatinine; Disease Progression; Diuretics; Double-Blind Method; Drug Combinations; Female; Glomerular Filtration Rate; Humans; Hydrochlorothiazide; Hypertension; Kidney Failure, Chronic; Male; Middle Aged; Risk Factors | 2010 |
Long-term efficacy of a combination of amlodipine and olmesartan medoxomil ± hydrochlorothiazide in patients with hypertension stratified by age, race and diabetes status: a substudy of the COACH trial.
Topics: Age Factors; Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Diuretics; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Middle Aged; Olmesartan Medoxomil; Placebo Effect; Racial Groups; Tetrazoles; Time Factors; Treatment Outcome; United States | 2010 |
The combination of amlodipine and angiotensin receptor blocker or diuretics in high-risk hypertensive patients: rationale, design and baseline characteristics.
Topics: Aged; Amiloride; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Calcium Channel Blockers; Cardiovascular Diseases; Chi-Square Distribution; China; Diuretics; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Kaplan-Meier Estimate; Male; Middle Aged; Research Design; Risk Assessment; Risk Factors; Telmisartan; Time Factors; Treatment Outcome | 2011 |
Treatment of hypertension: postmarketing surveillance study results of telmisartan monotherapy, fixed dose combination of telmisartan + hydrochlorothiazide/amlodipine.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; India; Male; Middle Aged; Telmisartan; Treatment Outcome | 2009 |
Angiotensin receptor blocker/diuretic combination preserves insulin responses in obese hypertensives.
Topics: Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Blood Glucose; Blood Pressure; Body Mass Index; Calcium Channel Blockers; Diuretics; Drug Therapy, Combination; Female; Glucose Tolerance Test; Humans; Hydrochlorothiazide; Hypertension; Insulin; Male; Middle Aged; Obesity; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2010 |
24-hour ambulatory blood pressure in the ACCOMPLISH trial.
Topics: Amlodipine; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Cardiovascular Diseases; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension | 2010 |
Cardiovascular events during differing hypertension therapies in patients with diabetes.
Topics: Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Blood Pressure; Coronary Disease; Diabetes Complications; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Risk Factors | 2010 |
Triple therapy with olmesartan medoxomil, amlodipine besylate, and hydrochlorothiazide in adult patients with hypertension: The TRINITY multicenter, randomized, double-blind, 12-week, parallel-group study.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Olmesartan Medoxomil; Severity of Illness Index; Tetrazoles | 2010 |
Evaluation of pharmacokinetic interactions between amlodipine, valsartan, and hydrochlorothiazide in patients with hypertension.
Topics: Adolescent; Adult; Amlodipine; Amlodipine, Valsartan Drug Combination; Antihypertensive Agents; Dose-Response Relationship, Drug; Drug Combinations; Drug Interactions; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Tetrazoles; Valine; Valsartan | 2011 |
Triple combination therapy with amlodipine, valsartan, and hydrochlorothiazide vs dual combination therapy with amlodipine and hydrochlorothiazide for stage 2 hypertensive patients.
Topics: Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2010 |
24-Hour ambulatory blood pressure response to combination valsartan/hydrochlorothiazide and amlodipine/hydrochlorothiazide in stage 2 hypertension by ethnicity: the EVALUATE study.
Topics: Aged; Aged, 80 and over; Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Double-Blind Method; Drug Combinations; Ethnicity; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Racial Groups; Regression Analysis; Severity of Illness Index; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2010 |
Olmesartan/amlodipine vs olmesartan/hydrochlorothiazide in hypertensive patients with metabolic syndrome: the OLAS study.
Topics: Adiponectin; Adult; Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; C-Reactive Protein; Comorbidity; Cytokines; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Incidence; Insulin Resistance; Intercellular Adhesion Molecule-1; Male; Metabolic Syndrome; Middle Aged; Prospective Studies; Single-Blind Method; Tetrazoles; Treatment Outcome; Vascular Cell Adhesion Molecule-1 | 2011 |
Efficacy and tolerability of aliskiren 300 mg/hydrochlorothiazide 25 mg (± amlodipine 5 mg) in hypertensive patients not controlled by candesartan 32 mg plus HCT 25 mg.
Topics: Adult; Aged; Algorithms; Amides; Amlodipine; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Dose-Response Relationship, Drug; Drug Combinations; Drug Resistance; Female; Fumarates; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Tetrazoles; Treatment Failure; Treatment Outcome | 2011 |
Efficacy and duration of benazepril plus amlodipine or hydrochlorothiazide on 24-hour ambulatory systolic blood pressure control.
Topics: Aged; Amlodipine; Analysis of Variance; Antihypertensive Agents; Benzazepines; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Male; Middle Aged; Prospective Studies; Time Factors; Treatment Outcome | 2011 |
24-Hour ambulatory blood pressure control with triple-therapy amlodipine, valsartan and hydrochlorothiazide in patients with moderate to severe hypertension.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amlodipine; Antihypertensive Agents; Blood Pressure Monitoring, Ambulatory; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Tetrazoles; Valine; Valsartan | 2011 |
Fixed-combination of amlodipine and diuretic chronotherapy in the treatment of essential hypertension: improved blood pressure control with bedtime dosing-a multicenter, open-label randomized study.
Topics: Aged; Amlodipine; Blood Pressure; Calcium Channel Blockers; Diuretics; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged | 2011 |
Rationale and design of the Newer Versus Older Antihypertensive Agents in African Hypertensive Patients (NOAAH) trial.
Topics: Adult; Africa South of the Sahara; Aged; Amlodipine; Antihypertensive Agents; Bisoprolol; Black People; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Diuretics; Drug Combinations; Female; Humans; Hydralazine; Hydrochlorothiazide; Hypertension; Male; Methyldopa; Middle Aged; Research Design; Risk Factors; Tetrazoles; Valine; Valsartan | 2011 |
Management of hypertension in patients with diabetes using an amlodipine-, olmesartan medoxomil-, and hydrochlorothiazide-based titration regimen.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amlodipine; Antihypertensive Agents; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug Combinations; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Olmesartan Medoxomil; Tetrazoles; Treatment Outcome | 2011 |
Peripheral and central blood pressure responses of combination aliskiren/hydrochlorothiazide and amlodipine monotherapy in African American patients with stage 2 hypertension: the ATLAAST trial.
Topics: Adult; Amides; Amlodipine; Antihypertensive Agents; Black or African American; Blood Pressure; Brachial Artery; Diarrhea; Double-Blind Method; Drug Therapy, Combination; Female; Fumarates; Headache; Humans; Hydrochlorothiazide; Hypertension; Incidence; Male; Middle Aged; Prospective Studies; Severity of Illness Index; Treatment Outcome | 2011 |
A titrate-to-goal study of switching patients uncontrolled on antihypertensive monotherapy to fixed-dose combinations of amlodipine and olmesartan medoxomil ± hydrochlorothiazide.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Algorithms; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Calcium Channel Blockers; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Self Report; Tetrazoles; Titrimetry; Young Adult | 2011 |
Combination angiotensin-receptor blocker (ARB)/calcium channel blocker with HCTZ vs the maximal recommended dose of an ARB with HCTZ in patients with stage 2 hypertension: the exforge as compared to losartan treatment in stage 2 systolic hypertension (EXA
Topics: Amlodipine; Angiotensin Receptor Antagonists; Blood Pressure; Calcium Channel Blockers; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Middle Aged; Severity of Illness Index; Tetrazoles; Treatment Outcome; United States; Valine; Valsartan | 2011 |
Predictors of systolic BP <140 mmHg and systolic BP level by randomly assigned treatment group (benazepril plus amlodipine or hydrochlorothiazide) in the ACCOMPLISH Study.
Topics: Amlodipine; Antihypertensive Agents; Benzazepines; Drug Therapy, Combination; Electrocardiography; Female; Humans; Hydrochlorothiazide; Hypertension; Logistic Models; Male; Systole | 2012 |
Aliskiren as add-on therapy in the treatment of hypertensive diabetic patients inadequately controlled with valsartan/HCT combination: a placebo-controlled study.
Topics: Aged; Amides; Amlodipine; Antihypertensive Agents; Blood Pressure; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Female; Fumarates; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Patient Dropouts; Potassium; Single-Blind Method | 2011 |
Plasma fibrin clot properties in arterial hypertension and their modification by antihypertensive medication.
Topics: Adult; Amlodipine; Antihypertensive Agents; Bisoprolol; Blood Coagulation; Female; Fibrin; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Middle Aged; Quinapril; Tetrahydroisoquinolines | 2012 |
Office and ambulatory blood pressure-lowering effects of combination valsartan/hydrochlorothiazide vs. hydrochlorothiazide-based therapy in obese, hypertensive patients.
Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Comorbidity; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Obesity; Office Visits; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2011 |
Distinct effects of fixed combinations of valsartan with either amlodipine or hydrochlorothiazide on lipoprotein subfraction profile in patients with hypertension.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Cholesterol; Female; Humans; Hydrochlorothiazide; Hypertension; Lipoproteins, HDL; Lipoproteins, LDL; Male; Middle Aged; Particle Size; Tetrazoles; Triglycerides; Valine; Valsartan | 2013 |
24-hour efficacy and safety of Triple-Combination Therapy With Olmesartan, Amlodipine, and Hydrochlorothiazide: the TRINITY ambulatory blood pressure substudy.
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure Monitoring, Ambulatory; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Severity of Illness Index; Tetrazoles; Time Factors | 2011 |
Comparison of aliskiren/hydrochlorothiazide combination therapy and amlodipine monotherapy in patients with stage 2 systolic hypertension and type 2 diabetes mellitus.
Topics: Amides; Amlodipine; Analysis of Variance; Antihypertensive Agents; Blood Pressure; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Fumarates; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Renin; Systole | 2011 |
Ambulatory blood pressure response to triple therapy with an angiotensin-receptor blocker (ARB), calcium-channel blocker (CCB), and HCTZ versus dual therapy with an ARB and HCTZ.
Topics: Amlodipine; Angiotensin Receptor Antagonists; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Middle Aged; Tetrazoles; Valine; Valsartan | 2011 |
Renal outcomes in hypertensive Black patients at high cardiovascular risk.
Topics: Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Biomarkers; Black or African American; Blood Pressure; Calcium Channel Blockers; Cardiovascular Diseases; Chi-Square Distribution; Creatinine; Diuretics; Double-Blind Method; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Humans; Hydrochlorothiazide; Hypertension; Incidence; Kaplan-Meier Estimate; Kidney; Kidney Failure, Chronic; Male; Middle Aged; Multivariate Analysis; Proportional Hazards Models; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; United States; Up-Regulation | 2012 |
Antihypertensive and metabolic effects of Angiotensin receptor blocker/diuretic combination therapy in obese, hypertensive African American and white patients.
Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Biomarkers; Black or African American; Blood Glucose; Diuretics; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hyperglycemia; Hypertension; Insulin; Intention to Treat Analysis; Male; Middle Aged; Obesity, Abdominal; Prediabetic State; Tetrazoles; Treatment Outcome; Valine; Valsartan; White People | 2013 |
Combination of amlodipine plus angiotensin receptor blocker or diuretics in high-risk hypertensive patients: a 96-week efficacy and safety study.
Topics: Aged; Amiloride; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Cardiovascular Diseases; China; Diuretics; Dose-Response Relationship, Drug; Drug Combinations; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Prospective Studies; Risk Factors; Telmisartan; Time Factors; Treatment Outcome | 2012 |
Effects of valsartan versus olmesartan addition to amlodipine/hydrochlorothiazide combination in treating stage 2 hypertensive patients.
Topics: Adult; Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Tetrazoles; Valine; Valsartan | 2012 |
Long-term efficacy and safety of triple-combination therapy with olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide for hypertension.
Topics: Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Diuretics; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Severity of Illness Index; Tetrazoles; Time Factors | 2012 |
[Effects of valsartan combined with amlodipine or hydrochlorothiazide regimen on blood pressure variation in elderly hypertensive patients].
Topics: Aged; Amlodipine; Blood Pressure; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2012 |
Effects of valsartan or ramipril addition to amlodipine/hydrochlorothiazide combination on left ventricular mass in diabetic hypertensive patients with left ventricular hypertrophy.
Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Ramipril; Tetrazoles; Valine; Valsartan | 2012 |
Progress report on the first sub-Saharan Africa trial of newer versus older antihypertensive drugs in native black patients.
Topics: Administration, Oral; Adult; Africa South of the Sahara; Aged; Amlodipine; Amlodipine, Valsartan Drug Combination; Antihypertensive Agents; Bisoprolol; Black People; Blood Pressure; Diuretics; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Patient Dropouts; Patient Selection; Risk Factors; Tablets; Tetrazoles; Time Factors; Treatment Outcome | 2012 |
Change in high-sensitive cardiac troponin T on hypertensive treatment.
Topics: Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Biomarkers; Blood Pressure; Calcium Channel Blockers; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Middle Aged; Natriuretic Peptide, Brain; Troponin T | 2013 |
Efficacy of amlodipine/olmesartan ± hydrochlorothiazide in patients uncontrolled on prior calcium channel blocker or angiotensin II receptor blocker monotherapy.
Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Angiotensin Receptor Antagonists; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Comorbidity; Dose-Response Relationship, Drug; Drug Combinations; Drug Therapy, Combination; Ethnicity; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Tetrazoles | 2012 |
Comparison of the efficacy and safety profiles of two fixed-dose combinations of antihypertensive agents, amlodipine/benazepril versus valsartan/hydrochlorothiazide, in patients with type 2 diabetes mellitus and hypertension: a 16-week, multicenter, rando
Topics: Aged; Albuminuria; Amlodipine; Analysis of Variance; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Biomarkers; Blood Glucose; Blood Pressure; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Diuretics; Double-Blind Method; Drug Combinations; Female; Glycated Hemoglobin; Humans; Hydrochlorothiazide; Hypertension; Lipids; Male; Middle Aged; Prospective Studies; Taiwan; Tetrazoles; Time Factors; Treatment Outcome; Uric Acid; Valine; Valsartan | 2012 |
Triple-Combination therapy with olmesartan, amlodipine, and hydrochlorothiazide in black and non-black study participants with hypertension: the TRINITY randomized, double-blind, 12-week, parallel-group study.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Black People; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Tetrazoles | 2012 |
Randomized Polypill crossover trial in people aged 50 and over.
Topics: Aged; Amlodipine; Anticholesteremic Agents; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypercholesterolemia; Hypertension; Losartan; Male; Middle Aged; Placebos; Simvastatin | 2012 |
Clinic and ambulatory blood pressure lowering effect of aliskiren/amlodipine/hydrochlorothiazide combination in patients with moderate-to-severe hypertension: a randomized active-controlled trial.
Topics: Aged; Amides; Amlodipine; Antihypertensive Agents; Double-Blind Method; Drug Therapy, Combination; Female; Fumarates; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Placebos; Severity of Illness Index; Single-Blind Method | 2012 |
Efficacy and safety of triple antihypertensive therapy with the olmesartan/amlodipine/hydrochlorothiazide combination.
Topics: Adult; Aged; Aging; Amlodipine; Antihypertensive Agents; Double-Blind Method; Drug Therapy, Combination; Endpoint Determination; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Tetrazoles; Young Adult | 2012 |
Cardiovascular outcomes in hypertensive patients: comparing single-agent therapy with combination therapy.
Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Prognosis; Retrospective Studies; Stroke; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2012 |
Efficacy of amlodipine/olmesartan medoxomil ± HCTZ in obese patients uncontrolled on antihypertensive monotherapy.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Obesity; Olmesartan Medoxomil; Tetrazoles | 2012 |
Olmesartan/amlodipine/hydrochlorothiazide in participants with hypertension and diabetes, chronic kidney disease, or chronic cardiovascular disease: a subanalysis of the multicenter, randomized, double-blind, parallel-group TRINITY study.
Topics: Aged; Amlodipine; Antihypertensive Agents; Cardiovascular Diseases; Diabetes Complications; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Olmesartan Medoxomil; Renal Insufficiency, Chronic; Tetrazoles | 2012 |
Safety and efficacy of aliskiren/amlodipine/hydrochlorothiazide triple combination in patients with moderate to severe hypertension: a 54-week, open-label study.
Topics: Adult; Aged; Amides; Amlodipine; Antihypertensive Agents; Biological Availability; Blood Pressure; Drug Monitoring; Drug Therapy, Combination; Female; Fumarates; Humans; Hydrochlorothiazide; Hypertension; Middle Aged; Pharmacovigilance; Severity of Illness Index; Treatment Outcome | 2012 |
Effects of body size and hypertension treatments on cardiovascular event rates: subanalysis of the ACCOMPLISH randomised controlled trial.
Topics: Aged; Amlodipine; Antihypertensive Agents; Benzazepines; Body Mass Index; Body Size; Body Weight; Cardiovascular Diseases; Double-Blind Method; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Obesity | 2013 |
Efficacy of an amlodipine/olmesartan treatment algorithm in patients with or without type 2 diabetes and hypertension (a secondary analysis of the BP-CRUSH study).
Topics: Adult; Aged; Algorithms; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Drug Combinations; Drug Substitution; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Olmesartan Medoxomil; Prospective Studies; Sodium Chloride Symporter Inhibitors; Tetrazoles; Time Factors; Treatment Outcome | 2013 |
Low-grade inflammation and ambulatory blood pressure response to antihypertensive treatment: the ALPHABET study.
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Dose-Response Relationship, Drug; Drug Combinations; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Inflammation; Losartan; Male; Middle Aged; Treatment Outcome | 2013 |
A comparative pharmacokinetic study of a fixed dose combination for essential hypertensive patients: a randomized crossover study in healthy human volunteers.
Topics: Adolescent; Adult; Amlodipine; Benzimidazoles; Benzoates; Cross-Over Studies; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Hypoglycemic Agents; Middle Aged; Telmisartan | 2013 |
Efficacy and effects on lipid metabolism of combination treatment with losartan + hydrochlorothiazide versus losartan + amlodipine: a 48-week prospective, multicenter, randomized, open-label trial.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Lipid Metabolism; Losartan; Male; Middle Aged; Prospective Studies | 2013 |
Combination of antihypertensive therapy in the elderly, multicenter investigation (CAMUI) trial: results after 1 year.
Topics: Aged; Aged, 80 and over; Amlodipine; Angiotensin Receptor Antagonists; Antihypertensive Agents; Calcium Channel Blockers; Cognition; Diuretics; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male | 2013 |
Efficacy of initiating therapy with amlodipine and hydrochlorothiazide or their combination in hypertensive Nigerians.
Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Antihypertensive Agents; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Nigeria; Treatment Outcome | 2013 |
Combined olmesartan, amlodipine, and hydrochlorothiazide therapy in randomized patients with hypertension: a subgroup analysis of the TRINITY study by age.
Topics: Adolescent; Adult; Age Factors; Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Double-Blind Method; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Olmesartan Medoxomil; Tetrazoles | 2013 |
Comparison of benazepril plus amlodipine or hydrochlorothiazide in high-risk patients with hypertension and coronary artery disease.
Topics: Aged; Amlodipine; Antihypertensive Agents; Benzazepines; Coronary Artery Disease; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Prospective Studies; Risk Assessment | 2013 |
Effects of aerobic exercise and drug therapy on blood pressure and antihypertensive drugs: a randomized controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Amiloride; Amlodipine; Antihypertensive Agents; Blood Pressure; Diuretics; Drug Combinations; Exercise; Exercise Therapy; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Treatment Outcome | 2013 |
Effects of CPAP on "vascular" risk factors in patients with obstructive sleep apnea and arterial hypertension.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Arterial Pressure; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Continuous Positive Airway Pressure; Diuretics; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Manometry; Middle Aged; Polysomnography; Predictive Value of Tests; Pulse Wave Analysis; Risk Factors; Russia; Severity of Illness Index; Sleep Apnea, Obstructive; Tetrazoles; Treatment Outcome; Valine; Valsartan; Vascular Stiffness | 2013 |
Effects of demographics on the antihypertensive efficacy of triple therapy with amlodipine, valsartan, and hydrochlorothiazide for moderate to severe hypertension.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amlodipine; Antihypertensive Agents; Blood Pressure; Demography; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Severity of Illness Index; Tetrazoles; Valine; Valsartan; Young Adult | 2013 |
Efficacy of newer versus older antihypertensive drugs in black patients living in sub-Saharan Africa.
Topics: Adult; Africa South of the Sahara; Amlodipine; Antihypertensive Agents; Bisoprolol; Black People; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2013 |
Efficacy of amlodipine/olmesartan medoxomil ± hydrochlorothiazide in patients aged ≥ 65 or < 65 years with uncontrolled hypertension on prior monotherapy.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Amlodipine; Antihypertensive Agents; Blood Pressure Monitoring, Ambulatory; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Olmesartan Medoxomil; Prospective Studies; Tetrazoles; Treatment Outcome; Young Adult | 2013 |
Olmesartan/amlodipine/hydrochlorothiazide in obese participants with hypertension: a TRINITY subanalysis.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Body Mass Index; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Obesity; Olmesartan Medoxomil; Prevalence; Tetrazoles; Treatment Outcome | 2013 |
Effect of renin-angiotensin system blockade on soluble Klotho in patients with type 2 diabetes, systolic hypertension, and albuminuria.
Topics: Aged; Albuminuria; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Biomarkers; Blood Pressure; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diuretics; Female; Glucuronidase; Hospitals, University; Humans; Hydrochlorothiazide; Hypertension; Klotho Proteins; London; Male; Middle Aged; Phosphates; Pulse Wave Analysis; Renin-Angiotensin System; Systole; Tetrazoles; Time Factors; Treatment Outcome; Valine; Valsartan | 2013 |
Anti-hypertensive strategies in patients with MEtabolic parameters, DIabetes mellitus and/or NephropAthy (the M E D I N A study).
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Diuretics; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Diseases; Losartan; Male; Metabolic Syndrome; Middle Aged; Risk Factors; Single-Blind Method | 2014 |
Comparative effectiveness of a fixed-dose combination of losartan + HCTZ versus bisoprolol + HCTZ in patients with moderate-to-severe hypertension: results of the 6-month ELIZA trial.
Topics: Adrenergic beta-1 Receptor Antagonists; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Bisoprolol; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Chi-Square Distribution; Diuretics; Doxazosin; Drug Combinations; Drug Therapy, Combination; Electrocardiography; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Middle Aged; Pulse Wave Analysis; Severity of Illness Index; Time Factors; Treatment Outcome; Ukraine; Vascular Stiffness | 2013 |
Comparative effect of canrenone or hydrochlorothiazide addition to valsartan/amlodipine combination on urinary albumin excretion in well-controlled type 2 diabetic hypertensive patients with microalbuminuria.
Topics: Adult; Aged; Albuminuria; Amlodipine; Amlodipine, Valsartan Drug Combination; Antihypertensive Agents; Canrenone; Diabetes Mellitus, Type 2; Diuretics; Drug Combinations; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Prospective Studies; Tetrazoles | 2014 |
[Possibilities of rational combination antihypertensive therapy: results of HEMERA international clinical trial].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amlodipine; Antihypertensive Agents; Blood Pressure; Diuretics; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Middle Aged; Prospective Studies; Ramipril; Treatment Outcome; Young Adult | 2013 |
TRIple pill vs Usual care Management for Patients with mild-to-moderate Hypertension (TRIUMPH): Study protocol.
Topics: Adult; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Calcium Channel Blockers; Diuretics; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Male; Prospective Studies; Severity of Illness Index; Telmisartan; Treatment Outcome | 2014 |
The effect of aliskiren versus ramipril-based treatment on the Ambulatory Arterial Stiffness Index in hypertensive patients.
Topics: Adult; Aged; Amides; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Drug Therapy, Combination; Fumarates; Greece; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Predictive Value of Tests; Ramipril; Renin-Angiotensin System; Sodium Chloride Symporter Inhibitors; Time Factors; Treatment Outcome; Vascular Stiffness; Vasodilator Agents | 2014 |
Efficacy and safety of olmesartan/amlodipine/hydrochlorothiazide in patients with hypertension not at goal with mono, dual or triple drug therapy: results of the CHAMPiOn study.
Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Olmesartan Medoxomil; Prospective Studies; Tetrazoles; Treatment Outcome | 2014 |
Aliskiren alone or with other antihypertensives in the elderly with borderline and stage 1 hypertension: the APOLLO trial.
Topics: Aged; Amides; Amlodipine; Antihypertensive Agents; Blood Pressure; Double-Blind Method; Drug Therapy, Combination; Female; Fumarates; Humans; Hydrochlorothiazide; Hypertension; Male; Medication Adherence; Potassium; Treatment Outcome | 2014 |
Triple-combination treatment with olmesartan medoxomil/amlodipine/ hydrochlorothiazide in Hispanic/Latino patients with hypertension: the TRINITY study.
Topics: Aged; Amlodipine; Antihypertensive Agents; Double-Blind Method; Female; Hispanic or Latino; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Least-Squares Analysis; Male; Middle Aged; Olmesartan Medoxomil; Tetrazoles | 2014 |
Open-label study assessing the long-term efficacy and safety of triple olmesartan/amlodipine/hydrochlorothiazide combination therapy for hypertension.
Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Dose-Response Relationship, Drug; Drug Monitoring; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Tetrazoles; Time; Treatment Outcome | 2014 |
Comparison of the antialbuminuric effects of benidipine and hydrochlorothiazide in Renin-Angiotensin System (RAS) inhibitor-treated hypertensive patients with albuminuria: the COSMO-CKD (COmbination Strategy on Renal Function of Benidipine or Diuretics Tr
Topics: Adult; Aged; Albuminuria; Amlodipine; Blood Pressure; Dihydropyridines; Female; Glomerular Filtration Rate; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Renal Insufficiency, Chronic; Renin-Angiotensin System | 2014 |
Efficacy and tolerability of amlodipine camsylate/losartan 5/100-mg versus losartan/hydrochlorothiazide 100/12.5-mg fixed-dose combination in hypertensive patients nonresponsive to losartan 100-mg monotherapy.
Topics: Adult; Amlodipine; Antihypertensive Agents; Blood Pressure; Double-Blind Method; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Middle Aged; Treatment Outcome | 2014 |
[Optimization of arterial hypertension management by the use of two- and three-drugs fixed dose combinations at the daily stay department].
Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Day Care, Medical; Dose-Response Relationship, Drug; Drug Combinations; Drug Monitoring; Drug Synergism; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2014 |
Efficacy and tolerability of triple-combination therapy with olmesartan, amlodipine, and hydrochlorothiazide: a subgroup analysis of patients stratified by hypertension severity, age, sex, and obesity.
Topics: Adult; Age Factors; Aged; Amlodipine; Blood Pressure; Body Mass Index; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Obesity; Sex Factors; Tetrazoles | 2014 |
Efficacy and safety of fixed-dose losartan/hydrochlorothiazide/amlodipine combination versus losartan/hydrochlorothiazide combination in Japanese patients with essential hypertension.
Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Drug Combinations; Drug Monitoring; Essential Hypertension; Female; Humans; Hydrochlorothiazide; Hypertension; Japan; Losartan; Male; Middle Aged; Treatment Outcome | 2015 |
Fixed-dose combination of losartan and hydrochlorothiazide significantly improves endothelial function in uncontrolled hypertension by low-dose amlodipine: a randomized study.
Topics: Aged; Amlodipine; Antihypertensive Agents; Brachial Artery; Drug Therapy, Combination; Endothelium, Vascular; Female; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Pulsatile Flow; Treatment Outcome | 2014 |
Amlodipine+benazepril is superior to hydrochlorothiazide+benazepril irrespective of baseline pulse pressure: subanalysis of the ACCOMPLISH trial.
Topics: Aged; Amlodipine; Antihypertensive Agents; Benzazepines; Blood Pressure; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Incidence; Male; Middle Aged; Myocardial Infarction; Retrospective Studies; Risk Factors; Stroke; Treatment Outcome | 2015 |
Pharmacogenomics of hypertension: a genome‐wide, placebo‐controlled cross‐over study, using four classes of antihypertensive drugs.
Topics: Adult; Aldehyde Oxidoreductases; Amlodipine; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Bisoprolol; Blood Pressure Monitoring, Ambulatory; Chloride Channels; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Essential Hypertension; Finland; Genome-Wide Association Study; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Membrane Proteins; Meta-Analysis as Topic; Microfilament Proteins; Middle Aged; Mutation, Missense; Pharmacogenetics; Polymorphism, Single Nucleotide; Severity of Illness Index; Tetrazoles; Treatment Outcome | 2015 |
Prospective randomized study of the tolerability and efficacy of combination therapy for hypertensive chronic kidney disease: results of the PROTECT-CKD study.
Topics: Adult; Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Diuretics; Drug Therapy, Combination; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension, Renal; Losartan; Male; Middle Aged; Prospective Studies; Renal Insufficiency, Chronic; Young Adult | 2015 |
Add-on effect of hydrochlorothiazide 12.5 mg in Japanese subjects with essential hypertension uncontrolled with losartan 50 mg and amlodipine 5 mg.
Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Antihypertensive Agents; Blood Pressure; Double-Blind Method; Drug Therapy, Combination; Essential Hypertension; Female; Humans; Hydrochlorothiazide; Hypertension; Japan; Losartan; Male; Middle Aged; Single-Blind Method; Treatment Outcome; Young Adult | 2015 |
[Changes of twenty-four-hour profile blood pressure and its correction of patients with arterial hypertension on the background of combined antihypertensive therapy application].
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Drug Combinations; Drug Therapy, Combination; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged | 2014 |
A multicenter, non-comparative study to evaluate the efficacy and safety of fixed-dose olmesartan/amlodipine in Korean patients with hypertension who are naïve or non-responders to anti-hypertensive monotherapy (ACE-HY study).
Topics: Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Incidence; Male; Middle Aged; Prospective Studies; Republic of Korea; Tetrazoles; Treatment Outcome | 2015 |
Visit-to-visit variability and seasonal variation in blood pressure: Combination of Antihypertensive Therapy in the Elderly, Multicenter Investigation (CAMUI) Trial subanalysis.
Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Prospective Studies; Seasons; Treatment Outcome | 2015 |
Health-related quality of life impact of a triple combination of olmesartan medoxomil, amlodipine besylate and hydrochlorotiazide in subjects with hypertension.
Topics: Adult; Aged; Amlodipine; Analysis of Variance; Antihypertensive Agents; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Olmesartan Medoxomil; Quality of Life; Tetrazoles; Treatment Outcome | 2015 |
Assessment of glomerular filtration rate based on alterations of serum brain-derived neurotrophic factor in type 2 diabetic subjects treated with amlodipine/benazepril or valsartan/hydrochlorothiazide.
Topics: Aged; Amlodipine; Antihypertensive Agents; Benzazepines; Brain-Derived Neurotrophic Factor; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Glomerular Filtration Rate; Humans; Hydrochlorothiazide; Male; Middle Aged; Valsartan | 2015 |
Adding Hydrochlorothiazide to Olmesartan/Amlodipine Increases Efficacy in Patients With Inadequate Blood Pressure Control on Dual-Combination Therapy.
Topics: Adult; Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Diuretics; Drug Synergism; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Olmesartan Medoxomil | 2016 |
Choice of Antihypertensive Combination Therapy Based on Daily Salt Intake.
Topics: Aged; Amlodipine; Amlodipine, Valsartan Drug Combination; Antihypertensive Agents; Blood Pressure; Diuretics; Drug Combinations; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Male; Metabolic Syndrome; Middle Aged; Potassium; Prospective Studies; Sodium; Sodium Chloride, Dietary; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2015 |
Modern medical treatment with or without carotid endarterectomy for severe asymptomatic carotid atherosclerosis.
Topics: Aged; Amlodipine; Arteriosclerosis; Atorvastatin; Carotid Artery Diseases; Endarterectomy, Carotid; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Life Style; Male | 2015 |
Efficacy and Safety Study of Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Combination Therapy in Patients with Hypertension Not Controlled with Olmesartan Medoxomil and Hydrochlorothiazide Combination Therapy: Results of a Randomized, Double-
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Olmesartan Medoxomil; Young Adult | 2016 |
Comparison of telmisartan/amlodipine and telmisartan/hydrochlorothiazide in the treatment of Japanese patients with uncontrolled hypertension: the TAT-Kobe study.
Topics: Aged; Aged, 80 and over; Amlodipine; Benzimidazoles; Benzoates; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Japan; Male; Middle Aged; Prospective Studies; Telmisartan | 2016 |
Effect of Diuretic or Calcium-Channel Blocker Plus Angiotensin-Receptor Blocker on Diastolic Function in Hypertensive Patients.
Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Angiotensin Receptor Antagonists; Blood Pressure; Calcium Channel Blockers; Diastole; Diuretics; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Middle Aged; Prospective Studies; Ventricular Dysfunction, Left | 2016 |
Effects of aerobic dance training on blood pressure in individuals with uncontrolled hypertension on two antihypertensive drugs: a randomized clinical trial.
Topics: Adult; Aged; Amiloride; Amlodipine; Antihypertensive Agents; Blood Pressure Determination; Combined Modality Therapy; Dance Therapy; Double-Blind Method; Drug Combinations; Exercise; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Treatment Outcome | 2016 |
Pharmacokinetic drug-drug interaction assessment between LCZ696, an angiotensin receptor neprilysin inhibitor, and hydrochlorothiazide, amlodipine, or carvedilol.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Aminobutyrates; Amlodipine; Angiotensin Receptor Antagonists; Antihypertensive Agents; Area Under Curve; Arizona; Biphenyl Compounds; Calcium Channel Blockers; Carbazoles; Carvedilol; Cross-Over Studies; Diuretics; Drug Administration Schedule; Drug Combinations; Drug Interactions; Drug Therapy, Combination; Female; Healthy Volunteers; Humans; Hydrochlorothiazide; Male; Metabolic Clearance Rate; Middle Aged; Models, Biological; Neprilysin; Propanolamines; Protease Inhibitors; Tetrazoles; Valsartan | 2015 |
The efficacy and long-term safety of a triple combination of 80 mg telmisartan, 5 mg amlodipine and 12.5 mg hydrochlorothiazide in Japanese patients with essential hypertension: a randomized, double-blind study with open-label extension.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Double-Blind Method; Drug Therapy, Combination; Essential Hypertension; Female; Humans; Hydrochlorothiazide; Hypertension; Japan; Male; Middle Aged; Telmisartan; Treatment Outcome | 2017 |
Effect of hydrochlorothiazide in addition to telmisartan/amlodipine combination for treating hypertensive patients uncontrolled with telmisartan/amlodipine: a randomized, double-blind study.
Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Antihypertensive Agents; Benzimidazoles; Benzoates; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Telmisartan; Treatment Outcome | 2017 |
Differential effects of lercanidipine/enalapril versus amlodipine/enalapril and hydrochlorothiazide/enalapril on target organ damage and sympathetic activation in non-obese essential hypertensive subjects.
Topics: Adult; Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Dihydropyridines; Double-Blind Method; Drug Therapy, Combination; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension; Kidney; Male; Middle Aged; Sympathetic Nervous System; Vascular Stiffness | 2016 |
Effect of losartan combined with amlodipine or with a thiazide on uric acid levels in hypertensive patients.
Topics: Amlodipine; Antihypertensive Agents; Biomarkers; Blood Pressure; Dose-Response Relationship, Drug; Drug Combinations; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Middle Aged; Time Factors; Treatment Outcome; Uric Acid | 2017 |
Quarter-dose quadruple combination therapy for initial treatment of hypertension: placebo-controlled, crossover, randomised trial and systematic review.
Topics: Administration, Oral; Amlodipine; Antihypertensive Agents; Atenolol; Biphenyl Compounds; Blood Pressure; Cross-Over Studies; Double-Blind Method; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Irbesartan; Male; Medication Adherence; Middle Aged; Tetrazoles; Treatment Outcome | 2017 |
Monotherapy with amlodipine or hydrochlorothiazide in patients with mild to moderate hypertension: Comparison of their efficacy and effects on electrolytes.
Topics: Adult; Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Determination; Dose-Response Relationship, Drug; Electrolytes; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Nigeria; Single-Blind Method; Treatment Outcome; Water-Electrolyte Imbalance | 2017 |
Combination Therapy Is Superior to Sequential Monotherapy for the Initial Treatment of Hypertension: A Double-Blind Randomized Controlled Trial.
Topics: Adolescent; Adult; Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Dose-Response Relationship, Drug; Double-Blind Method; Doxazosin; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Middle Aged; Treatment Outcome; Young Adult | 2017 |
A phase III, open-label, multicenter study to evaluate the safety and efficacy of long-term triple combination therapy with azilsartan, amlodipine, and hydrochlorothiazide in patients with essential hypertension.
Topics: Adult; Aged; Amlodipine; Benzimidazoles; Blood Pressure; Drug Administration Schedule; Drug Therapy, Combination; Essential Hypertension; Female; Humans; Hydrochlorothiazide; Male; Middle Aged; Oxadiazoles | 2018 |
Effects of triple combination therapy with azilsartan/amlodipine/hydrochlorothiazide on office/home blood pressure: a randomized-controlled trial in Japanese essential hypertensive patients.
Topics: Aged; Amlodipine; Antihypertensive Agents; Benzimidazoles; Blood Pressure; Double-Blind Method; Drug Therapy, Combination; Essential Hypertension; Female; Humans; Hydrochlorothiazide; Japan; Male; Middle Aged; Oxadiazoles; Treatment Outcome | 2018 |
Efficacy and Tolerability of Telmisartan/Amlodipine + Hydrochlorothiazide Versus Telmisartan/Amlodipine Combination Therapy for Essential Hypertension Uncontrolled With Telmisartan/Amlodipine: The Phase III, Multicenter, Randomized, Double-blind TAHYTI St
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Dizziness; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Essential Hypertension; Female; Headache; Humans; Hydrochlorothiazide; Male; Middle Aged; Telmisartan; Treatment Outcome; Young Adult | 2018 |
Rationale and design of the comparison of 3 combination therapies in lowering blood pressure in black Africans (CREOLE study): 2 × 3 factorial randomized single-blind multicenter trial.
Topics: Adult; Africa South of the Sahara; Aged; Amlodipine; Antihypertensive Agents; Black People; Drug Combinations; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Perindopril; Research Design; Single-Blind Method | 2018 |
The Precision HYpertenSIon Care (PHYSIC) study: a double-blind, randomized, repeated cross-over study.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Benzimidazoles; Biomarkers; Biphenyl Compounds; Blood Pressure; Blood Pressure Determination; Cross-Over Studies; Double-Blind Method; Female; Humans; Hydrochlorothiazide; Hypertension; Lisinopril; Male; Middle Aged; Precision Medicine; Randomized Controlled Trials as Topic; Research Design; Risk Factors; Tetrazoles | 2019 |
Treating Hypertension in Children With
Topics: Academic Medical Centers; Adolescent; Amlodipine; Antihypertensive Agents; Bayes Theorem; Blood Pressure Determination; Blood Pressure Monitoring, Ambulatory; Child; Cross-Over Studies; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Lisinopril; Male; Patient Preference; Precision Medicine; Texas; Treatment Outcome | 2019 |
Comparison of Dual Therapies for Lowering Blood Pressure in Black Africans.
Topics: Adult; Africa South of the Sahara; Aged; Amlodipine; Antihypertensive Agents; Black People; Blood Pressure; Drug Combinations; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Logistic Models; Male; Middle Aged; Perindopril; Single-Blind Method | 2019 |
Comparison of 24-Hour Ambulatory Central Blood Pressure Reduction Efficacy Between Fixed Amlodipine or Up-Titrated Hydrochlorothiazide Plus Losartan: The K-Central Study.
Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Double-Blind Method; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Middle Aged; Prospective Studies; Republic of Korea; Time Factors; Treatment Outcome | 2019 |
A Randomized, Double-blinded, Controlled, Multicentre Phase III Study to Evaluate the Efficacy and Safety of Telmisartan /Amlodipine/Hydrochlorothiazide Compared to Telmisartan/Hydrochlorothiazide in Patients with Essential Hypertension.
Topics: Amlodipine; Antihypertensive Agents; Drug Combinations; Drug Therapy, Combination; Essential Hypertension; Humans; Hydrochlorothiazide; Telmisartan | 2018 |
The association of smoothness index of central blood pressure with ambulatory carotid femoral pulse wave velocity after 20-week treatment with losartan in combination with amlodipine versus hydrochlorothiazide.
Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Carotid-Femoral Pulse Wave Velocity; Female; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Middle Aged | 2019 |
Polypill for Cardiovascular Disease Prevention in an Underserved Population.
Topics: Adult; Alabama; Amlodipine; Antihypertensive Agents; Atorvastatin; Cholesterol, LDL; Community Health Centers; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypertension; Losartan; Male; Medically Underserved Area; Medication Adherence; Middle Aged | 2019 |
Pharmacokinetic Interaction Among Telmisartan, Amlodipine, and Hydrochlorothiazide After a Single Oral Administration in Healthy Male Subjects.
Topics: Administration, Oral; Adult; Amlodipine; Antihypertensive Agents; Calcium Channel Blockers; Cross-Over Studies; Diuretics; Drug Interactions; Healthy Volunteers; Humans; Hydrochlorothiazide; Male; Middle Aged; Telmisartan; Young Adult | 2019 |
Circulating microparticles and central blood pressure according to antihypertensive strategy.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Cell-Derived Microparticles; Drug Therapy, Combination; Female; Flow Cytometry; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Prospective Studies; Rosuvastatin Calcium; Valsartan | 2019 |
Comparison of Blood Pressure Variability Between Losartan and Amlodipine in Essential Hypertension (COMPAS-BPV).
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Drug Therapy, Combination; Essential Hypertension; Female; Humans; Hydrochlorothiazide; Losartan; Male; Middle Aged | 2020 |
Adherence to triple-component antihypertensive regimens is higher with single-pill than equivalent two-pill regimens: A randomized controlled trial.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Drug Combinations; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Medication Adherence; Middle Aged; Tetrazoles; Treatment Outcome | 2021 |
Fixed-dose Combination of Metoprolol, Telmisartan, and Chlorthalidone for Essential Hypertension in Adults with Stable Coronary Artery Disease: Phase III Study.
Topics: Adult; Amlodipine; Antihypertensive Agents; Blood Pressure; Chlorthalidone; Coronary Artery Disease; Drug Therapy, Combination; Essential Hypertension; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Metoprolol; Telmisartan; Tetrazoles | 2022 |
A Differential Response to Antihypertensive Therapy in African Men and Women: Insights From the CREOLE Trial.
Topics: Amlodipine; Antihypertensive Agents; Black People; Blood Pressure; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Perindopril; Treatment Outcome | 2022 |
Effect of 3, 2-Drug Combinations of Antihypertensive Therapies on Blood Pressure Variability in Black African Patients: Secondary Analyses of the CREOLE Trial.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Drug Combinations; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Perindopril; Thiazides | 2022 |
Heterogeneity in Blood Pressure Response to 4 Antihypertensive Drugs: A Randomized Clinical Trial.
Topics: Amlodipine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Cross-Over Studies; Diuretics; Double-Blind Method; Female; Humans; Hydrochlorothiazide; Hypertension; Lisinopril; Male; Middle Aged; Precision Medicine | 2023 |
132 other study(ies) available for amlodipine and hydrochlorothiazide
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Contribution of ionization and lipophilicity to drug binding to albumin: a preliminary step toward biodistribution prediction.
Topics: Chromatography, Affinity; Hydrogen-Ion Concentration; Ions; Models, Molecular; Molecular Conformation; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Serum Albumin, Bovine; Ultracentrifugation | 2004 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Albuminuria in diabetes mellitus: relation to ambulatory versus office blood pressure and effects of cilazapril.
Topics: Adolescent; Adult; Aged; Albuminuria; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Blood Pressure Determination; Calcium Channel Blockers; Cilazapril; Diabetes Mellitus, Type 2; Diuretics; Drug Therapy, Combination; Electrocardiography; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Sodium Chloride Symporter Inhibitors | 1996 |
Treatment of hypertensive patients with diabetes.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Case-Control Studies; Cohort Studies; Diabetes Complications; Enalapril; Fosinopril; Humans; Hydrochlorothiazide; Hypertension; Isradipine; Nisoldipine; Randomized Controlled Trials as Topic | 1998 |
Key features of candesartan cilexetil and a comparison with other angiotensin II receptor antagonists.
Topics: Amlodipine; Angiotensin Receptor Antagonists; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Delayed-Action Preparations; Diuretics; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Losartan; Renin-Angiotensin System; Retrospective Studies; Sodium Chloride Symporter Inhibitors; Tetrazoles; Treatment Outcome | 1999 |
Modulation of tumor necrosis factor-alpha production with anti-hypertensive drugs.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Amlodipine; Animals; Antihypertensive Agents; Calcium Channel Blockers; Cells, Cultured; Dihydropyridines; Diuretics; Doxazosin; Humans; Hydrochlorothiazide; Interleukin-1; Interleukin-6; Lipopolysaccharides; Male; Metoprolol; Mice; Mice, Inbred BALB C; Monocytes; Nicardipine; Nitrobenzenes; Piperazines; Sodium Chloride Symporter Inhibitors; Tumor Necrosis Factor-alpha | 2000 |
[VALUE study underscores the significance of reaching aimed blood pressure values for minimizing cardiovascular risks].
Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diuretics; Double-Blind Method; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Prospective Studies; Randomized Controlled Trials as Topic; Risk Factors; Sodium Chloride Symporter Inhibitors; Tetrazoles; Time Factors; Valine; Valsartan | 2004 |
The Avoiding Cardiovascular events through COMbination therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial: a comparison of first-line combination therapies.
Topics: Amlodipine; Antihypertensive Agents; Benzazepines; Cardiovascular Diseases; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Risk Factors | 2005 |
Benazepril combined with either amlodipine or hydrochlorothiazide is more effective than monotherapy for blood pressure control and prevention of end-organ injury in hypertensive Dahl rats.
Topics: Acetylcholine; Administration, Oral; Amlodipine; Animals; Antihypertensive Agents; Benzazepines; Blood Pressure; Drug Therapy, Combination; Hydrochlorothiazide; Hypertension; Male; Rats; Rats, Inbred Dahl; Sodium Chloride, Dietary; Vasodilation | 2006 |
Antihypertensive agents have different ability to modulate arterial pressure and heart rate variability in 2K1C rats.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Atenolol; Autonomic Nervous System; Blood Pressure; Cardiovascular System; Heart Rate; Hydrochlorothiazide; Hypertension; Losartan; Male; Ramipril; Rats; Rats, Wistar; Sympathetic Nervous System | 2006 |
Lack of pharmacokinetic interactions of aliskiren, a novel direct renin inhibitor for the treatment of hypertension, with the antihypertensives amlodipine, valsartan, hydrochlorothiazide (HCTZ) and ramipril in healthy volunteers.
Topics: Adolescent; Adult; Amides; Amlodipine; Antihypertensive Agents; Drug Interactions; Drug Therapy, Combination; Female; Fumarates; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Ramipril; Renin; Renin-Angiotensin System; Tetrazoles; Valine; Valsartan | 2006 |
Pulsology reloaded: commentary on similar effects of treatment on central and brachial blood pressure in older hypertensive subjects.
Topics: Aged; Aged, 80 and over; Aging; Amlodipine; Antihypertensive Agents; Atenolol; Blood Pressure; Brachial Artery; Enalapril; Humans; Hydrochlorothiazide; Hypertension; Losartan; Manometry; Perindopril; Ultrasonography, Doppler | 2007 |
[Amlodipine is the better partner].
Topics: Aged; Amlodipine; Antihypertensive Agents; Benzazepines; Blood Pressure; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Randomized Controlled Trials as Topic; Treatment Outcome | 2008 |
[Unexpected study data for treatment of hypertension. Combination therapy with a diuretic not imperative].
Topics: Amlodipine; Antihypertensive Agents; Benzazepines; Cardiovascular Diseases; Cause of Death; Drug Combinations; Humans; Hydrochlorothiazide; Hypertension; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Sodium Chloride Symporter Inhibitors; Survival Analysis | 2008 |
Application in the STRATHE trial of a score system to compare the efficacy and the tolerability of different therapeutic strategies in the management of hypertension.
Topics: Amlodipine; Antihypertensive Agents; Atenolol; Double-Blind Method; Drug Therapy, Combination; France; Humans; Hydrochlorothiazide; Hypertension; Indapamide; Losartan; Perindopril; Randomized Controlled Trials as Topic; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2008 |
Adherence with multiple-combination antihypertensive pharmacotherapies in a US managed care database.
Topics: Adolescent; Adult; Age Factors; Aged; Amlodipine; Antihypertensive Agents; Drug Combinations; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Insurance Claim Review; Male; Managed Care Programs; Middle Aged; Patient Compliance; Tetrazoles; United States; Valine; Valsartan | 2008 |
Aliskiren for hypertension in adults.
Topics: Adult; Amides; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Drug Combinations; Fumarates; Humans; Hydrochlorothiazide; Hypertension; Renin; Treatment Outcome | 2008 |
Based treatment algorithm for essencial hypertension with olmesartan medoxomil.
Topics: Adult; Aged; Algorithms; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Olmesartan Medoxomil; Prospective Studies; Reference Values; Severity of Illness Index; Tetrazoles; Treatment Outcome | 2008 |
Does it matter how hypertension is controlled?
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Calcium Channel Blockers; Cardiovascular Diseases; Diuretics; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Risk | 2008 |
All thiazide-like diuretics are not chlorthalidone: putting the ACCOMPLISH study into perspective.
Topics: Amlodipine; Antihypertensive Agents; Benzazepines; Chlorthalidone; Diuretics; Humans; Hydrochlorothiazide; Hypertension; Multicenter Studies as Topic; Randomized Controlled Trials as Topic | 2009 |
[The ACCOMPLISH trial: are results really unexpected?].
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Calcium Channel Blockers; Diuretics; Humans; Hydrochlorothiazide; Hypertension; Randomized Controlled Trials as Topic | 2009 |
Will the results of the ACCOMPLISH trial affect the recommendations of JNC 8?
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Calcium Channel Blockers; Diuretics; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Practice Guidelines as Topic; Practice Patterns, Physicians'; Randomized Controlled Trials as Topic; Research Design; Treatment Outcome | 2009 |
Benazepril plus amlodipine or hydrochlorothiazide for hypertension.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Calcium Channel Blockers; Chlorthalidone; Diuretics; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Hypokalemia | 2009 |
Benazepril plus amlodipine or hydrochlorothiazide for hypertension.
Topics: Adrenergic beta-Antagonists; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Calcium Channel Blockers; Diuretics; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension | 2009 |
Benazepril plus amlodipine or hydrochlorothiazide for hypertension.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Blood Pressure; Calcium Channel Blockers; Diuretics; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension | 2009 |
Triple fixed-dose combination therapy: back to the past.
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Diastole; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Systole; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2009 |
Exforge HCT.
Topics: Amlodipine; Amlodipine, Valsartan Drug Combination; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Calcium Channel Blockers; Clinical Trials as Topic; Diuretics; Drug Combinations; Drug Costs; Humans; Hydrochlorothiazide; Hypertension; Tetrazoles; Valine; Valsartan | 2009 |
Effect of switching from amlodipine to combination therapy with telmisartan and low-dose hydrochlorothiazide.
Topics: Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Body Mass Index; Calcium Channel Blockers; Diuretics; Drug Therapy, Combination; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Telmisartan; Treatment Outcome; Uric Acid | 2009 |
Lessons from the ACCOMPLISH trial.
Topics: Amlodipine; Antihypertensive Agents; Benzazepines; Cardiovascular Diseases; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Multicenter Studies as Topic; Outcome Assessment, Health Care; Randomized Controlled Trials as Topic; Treatment Outcome | 2009 |
Effect of antihypertensive drug therapy on short-term heart rate variability in newly diagnosed essential hypertension.
Topics: Adult; Amlodipine; Antihypertensive Agents; Arrhythmia, Sinus; Atenolol; Enalapril; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Sinoatrial Node | 2010 |
Amlodipine/valsartan/hydrochlorothiazide: fixed-dose combination in hypertension.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Calcium Channel Blockers; Clinical Trials, Phase III as Topic; Drug Combinations; Humans; Hydrochlorothiazide; Hypertension; Tetrazoles; Valine; Valsartan | 2009 |
Composite renal endpoints: was ACCOMPLISH accomplished?
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Calcium Channel Blockers; Creatinine; Disease Progression; Diuretics; Drug Therapy, Combination; Glomerular Filtration Rate; Humans; Hydrochlorothiazide; Hypertension; Kidney Failure, Chronic; Renin-Angiotensin System | 2010 |
Role of valsartan, amlodipine and hydrochlorothiazide fixed combination in blood pressure control: an update.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Tetrazoles; Valine; Valsartan | 2010 |
Reversible effects of diuretics added to renin-angiotensin-aldosterone system blockade: impact on interpretation of long-term kidney function outcome.
Topics: Amlodipine; Chronic Disease; Data Interpretation, Statistical; Diuretics; Humans; Hydrochlorothiazide; Kidney Diseases; Renin-Angiotensin System; Time Factors | 2010 |
Tribenzor for hypertension.
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Clinical Trials as Topic; Drug Combinations; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Tetrazoles | 2010 |
Candesartan and amlodipine combination therapy provides powerful vascular protection in stroke-prone spontaneously hypertensive rats.
Topics: Acetylcholine; Amlodipine; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Vessels; Diuretics; Drug Therapy, Combination; Gene Expression Regulation; Hydrochlorothiazide; Male; Malondialdehyde; NADPH Oxidases; Rats; Rats, Inbred SHR; Rats, Wistar; Stroke; Superoxide Dismutase; Tetrazoles; Vasodilation; Vasodilator Agents | 2011 |
Simultaneous spectrophotometric determination of losartan potassium, amlodipine besilate and hydrochlorothiazide in pharmaceuticals by chemometric methods.
Topics: Amlodipine; Chemistry, Pharmaceutical; Hydrochlorothiazide; Least-Squares Analysis; Linear Models; Losartan; Multivariate Analysis; Principal Component Analysis; Spectrophotometry, Ultraviolet; Tablets | 2010 |
Annual drug update: 2010 in review.
Topics: Amlodipine; Antihypertensive Agents; Azasteroids; Clindamycin; Dermatologic Agents; Drug Combinations; Dutasteride; Humans; Hydrochlorothiazide; Imidazoles; Male; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Tetrazoles; Tretinoin; United States; United States Food and Drug Administration | 2011 |
Anti-inflammatory effects of anti-hypertensive agents: influence on interleukin-1β secretion by peripheral blood polymorphonuclear leukocytes from patients with essential hypertension.
Topics: Adult; Amlodipine; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Atenolol; Captopril; Case-Control Studies; Female; Humans; Hydrochlorothiazide; Hypertension; In Vitro Techniques; Inflammation Mediators; Interleukin-1beta; Lipopolysaccharides; Losartan; Male; Middle Aged; Neutrophils | 2011 |
The 'pyrrhic victory' of amlodipine over hydrochlorothiazide in the OLAS Study.
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Body Mass Index; Comorbidity; Drug Therapy, Combination; Endpoint Determination; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Life Style; Metabolic Syndrome; Tetrazoles; Treatment Outcome | 2011 |
The effect of antihypertensive agents in people at high risk of cardiovascular disease and diabetes: a view through smoke and mirrors.
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Comorbidity; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Metabolic Syndrome; Risk Factors; Tetrazoles; Treatment Outcome | 2011 |
Scintigraphic diagnosis of Erdheim-Chester disease.
Topics: Aged; Amlodipine; Antihypertensive Agents; Diabetes Mellitus, Type 2; Drug Combinations; Erdheim-Chester Disease; Gated Blood-Pool Imaging; Humans; Hydrochlorothiazide; Hypoglycemic Agents; Hypolipidemic Agents; Imidazoles; Knee Joint; Losartan; Male; Metformin; Positron-Emission Tomography; Prostatic Neoplasms; Simvastatin | 2011 |
The use of 24-h ambulatory blood pressure monitoring (ABPM) during the first cycle of sunitinib improves the diagnostic accuracy and management of hypertension in patients with advanced renal cancer.
Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Antihypertensive Agents; Antineoplastic Agents; Benzopyrans; Biphenyl Compounds; Blood Pressure Monitoring, Ambulatory; Carcinoma, Renal Cell; Ethanolamines; Female; Humans; Hydrochlorothiazide; Hypertension; Indoles; Irbesartan; Male; Middle Aged; Nebivolol; Prevalence; Pyrroles; Reproducibility of Results; Sunitinib; Tetrazoles; Time Factors; Treatment Outcome | 2011 |
Amlodipine + valsartan + hydrochlorothiazide. A 3-drug fixed-dose combination for hypertension: too many drawbacks.
Topics: Amlodipine; Antihypertensive Agents; Drug Combinations; Drug Packaging; Humans; Hydrochlorothiazide; Hypertension; Medication Errors; Tetrazoles; Valine; Valsartan | 2011 |
[Antihypertensive therapy in routine practice: fixed or free combination? Fixed combination scores with better prognosis].
Topics: Amlodipine; Amlodipine, Valsartan Drug Combination; Antihypertensive Agents; Drug Combinations; Humans; Hydrochlorothiazide; Hypertension; Medication Adherence; Myocardial Infarction; Stroke; Tetrazoles; Valine | 2011 |
STK39 variation predicts the ambulatory blood pressure response to losartan in hypertensive men.
Topics: Adult; Alleles; Amlodipine; Antihypertensive Agents; Bisoprolol; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Genotype; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Middle Aged; Polymorphism, Single Nucleotide; Protein Serine-Threonine Kinases | 2012 |
Combined aliskiren and amlodipine reduce albuminuria via reduction in renal inflammation in diabetic rats.
Topics: Albuminuria; Amides; Amlodipine; Animals; Antihypertensive Agents; Blood Pressure; Diabetes Mellitus, Experimental; Drug Therapy, Combination; Fumarates; Hydrochlorothiazide; Inflammation; Kidney; Male; Rats; Rats, Sprague-Dawley; Renin; Streptozocin | 2012 |
An economic evaluation of antihypertensive therapies based on clinical trials.
Topics: Amlodipine; Antihypertensive Agents; Atenolol; Blood Pressure; Drug Costs; Drug Therapy, Combination; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Middle Aged; Randomized Controlled Trials as Topic | 2012 |
Simple RP-HPLC method for determination of triple drug combination of valsartan, amlodipine and hydrochlorothiazide in human plasma.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Calcium Channel Blockers; Chromatography, High Pressure Liquid; Chromatography, Reverse-Phase; Diuretics; Drug Therapy, Combination; Guideline Adherence; Guidelines as Topic; Humans; Hydrochlorothiazide; Reproducibility of Results; Tetrazoles; Valine; Valsartan; Vasodilator Agents | 2012 |
Stability-indicating method for simultaneous estimation of olmesartan medoxomile, amlodipine besylate and hydrochlorothiazide by RP-HPLC in tablet dosage form.
Topics: Amlodipine; Chromatography, High Pressure Liquid; Chromatography, Reverse-Phase; Drug Stability; Hydrochlorothiazide; Imidazoles; Linear Models; Olmesartan Medoxomil; Reproducibility of Results; Sensitivity and Specificity; Tablets; Tetrazoles | 2012 |
[Hypertension: improved therapy adherence after switch to a fixed drug combinations].
Topics: Amlodipine; Antihypertensive Agents; Controlled Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Combinations; Drug Substitution; Germany; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Medication Adherence; Olmesartan Medoxomil; Tetrazoles | 2012 |
Efficacy and tolerability of fixed-dose amlodipine/olmesartan medoxomil with or without hydrochlorothiazide in Hispanic and non-Hispanic patients whose blood pressure is uncontrolled on antihypertensive monotherapy.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Drug Therapy, Combination; Female; Hispanic or Latino; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Olmesartan Medoxomil; Prospective Studies; Tetrazoles | 2012 |
Concurrent estimation of amlodipine besylate, hydrochlorothiazide and valsartan by RP-HPLC, HPTLC and UV-spectrophotometry.
Topics: Amlodipine; Chromatography, High Pressure Liquid; Chromatography, Reverse-Phase; Drug Combinations; Hydrochlorothiazide; Linear Models; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Tablets; Tetrazoles; Valine; Valsartan | 2014 |
Olmesartan-based therapies: an effective way to improve blood pressure control and cardiovascular protection.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Tetrazoles; Treatment Failure | 2013 |
[Telangiectasia during amlodipine therapy].
Topics: Amlodipine; Antihypertensive Agents; Bisoprolol; Calcium Channel Blockers; Drug Substitution; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Middle Aged; Ramipril; Telangiectasis | 2013 |
Pill burden in hypertensive patients treated with single-pill combination therapy--an observational study.
Topics: Aged; Aged, 80 and over; Amlodipine; Antihypertensive Agents; Cost of Illness; Drug Combinations; Drug Therapy, Combination; Female; Germany; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Prospective Studies; Tetrazoles; Valine; Valsartan | 2013 |
[Hypertension. Goal: achieving target blood pressure with only 1 pill daily].
Topics: Amlodipine; Antihypertensive Agents; Drug Combinations; Germany; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Randomized Controlled Trials as Topic; Tetrazoles | 2013 |
Comparative study between derivative spectrophotometry and multivariate calibration as analytical tools applied for the simultaneous quantitation of Amlodipine, Valsartan and Hydrochlorothiazide.
Topics: Amlodipine; Calibration; Chemistry Techniques, Analytical; Chromatography, High Pressure Liquid; Hydrochlorothiazide; Least-Squares Analysis; Multivariate Analysis; Reproducibility of Results; Spectrophotometry; Spectrophotometry, Ultraviolet; Tablets; Tetrazoles; Valine; Valsartan | 2013 |
Venoarterial extracorporeal membrane oxygenation for the management of massive amlodipine overdose.
Topics: Amlodipine; Extracorporeal Membrane Oxygenation; Humans; Hydrochlorothiazide; Lisinopril; Male; Middle Aged; Respiration, Artificial; Respiratory Insufficiency; Treatment Outcome | 2014 |
Commentary in support of a highly effective hypertension treatment algorithm.
Topics: Adult; Algorithms; Amlodipine; Antihypertensive Agents; Blood Pressure; Drug Combinations; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Lisinopril; Spironolactone; Treatment Outcome; United States | 2013 |
Different approaches in Partial Least Squares and Artificial Neural Network models applied for the analysis of a ternary mixture of Amlodipine, Valsartan and Hydrochlorothiazide.
Topics: Amlodipine; Antihypertensive Agents; Dosage Forms; Hydrochlorothiazide; Least-Squares Analysis; Neural Networks, Computer; Principal Component Analysis; Spectrophotometry, Ultraviolet; Tetrazoles; Valine; Valsartan | 2014 |
ARB-based single-pill platform to guide a practical therapeutic approach to hypertensive patients.
Topics: Administration, Oral; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Diuretics; Drug Combinations; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Medication Adherence; Risk Factors; Tablets; Tetrazoles; Treatment Outcome | 2014 |
Spectrophotometric methods for simultaneous determination of ternary mixture of amlodipine besylate, olmesartan medoxomil and hydrochlorothiazide.
Topics: Absorption; Amlodipine; Hydrochlorothiazide; Imidazoles; Olmesartan Medoxomil; Reproducibility of Results; Spectrophotometry; Tetrazoles; Water | 2014 |
Real-life effectiveness, safety, and tolerability of amlodipine/valsartan or amlodipine/valsartan/hydrochlorothiazide single-pill combination in patients with hypertension from Pakistan.
Topics: Adult; Aged; Amlodipine; Amlodipine, Valsartan Drug Combination; Antihypertensive Agents; Blood Pressure; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Prospective Studies; Tetrazoles | 2014 |
Simultaneous determination of aliskiren hemifumarate, amlodipine besylate, and hydrochlorothiazide in their triple mixture dosage form by capillary zone electrophoresis.
Topics: Amides; Amlodipine; Chromatography, High Pressure Liquid; Electrophoresis, Capillary; Fumarates; Hydrochlorothiazide | 2014 |
Clinical impact of patient adherence to a fixed-dose combination of olmesartan, amlodipine and hydrochlorothiazide.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Drug Combinations; Essential Hypertension; Europe; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Medication Adherence; Middle Aged; Prospective Studies; Risk Factors; Surveys and Questionnaires; Tetrazoles; Young Adult | 2014 |
Development and validation of a HPLC-PDA bioanalytical method for the simultaneous estimation of Aliskiren and Amlodipine in human plasma.
Topics: Acetonitriles; Amides; Amlodipine; Chemical Precipitation; Chromatography, High Pressure Liquid; Drug Stability; Fumarates; Humans; Hydrochlorothiazide; Limit of Detection; Sensitivity and Specificity | 2015 |
[Hypertension. Guidelines recommend fixed combinations].
Topics: Amlodipine; Antihypertensive Agents; Diabetes Mellitus, Type 2; Drug Combinations; Guideline Adherence; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Medication Adherence; Randomized Controlled Trials as Topic; Tetrazoles | 2014 |
Critical blood pressure threshold dependence of hypertensive injury and repair in a malignant nephrosclerosis model.
Topics: Amlodipine; Animals; Antihypertensive Agents; Blood Pressure; Disease Models, Animal; Drug Therapy, Combination; Enalapril; Humans; Hydralazine; Hydrochlorothiazide; Hypertension; Male; Nephrosclerosis; Rats; Rats, Inbred SHR; Reference Values; Treatment Outcome | 2014 |
Drug effects on the CVS in conscious rats: separating cardiac output into heart rate and stroke volume using PKPD modelling.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Amiloride; Amlodipine; Animals; Atropine; Enalapril; Hemodynamics; Hydrochlorothiazide; Hypertension; Male; Models, Biological; Prazosin; Propranolol; Rats, Inbred SHR; Rats, Inbred WKY | 2014 |
Real-world clinical experience of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide in hypertension: the EXCITE study.
Topics: Adult; Aged; Amlodipine; Amlodipine, Valsartan Drug Combination; Antihypertensive Agents; Asia; Blood Pressure; Double-Blind Method; Drug Combinations; Drug Monitoring; Female; Heart Failure; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Prospective Studies; Research Design; Tetrazoles; Treatment Outcome | 2014 |
If I had resistant hypertension.
Topics: Amlodipine; Antihypertensive Agents; Atorvastatin; Blood Pressure; Dose-Response Relationship, Drug; Drug Resistance; Drug Therapy, Combination; Heptanoic Acids; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Pyrroles; Spironolactone; Tetrazoles; Treatment Failure; Treatment Outcome | 2014 |
A medication adherence and persistence comparison of hypertensive patients treated with single-, double- and triple-pill combination therapy.
Topics: Adult; Aged; Amlodipine; Amlodipine, Valsartan Drug Combination; Antihypertensive Agents; Drug Combinations; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Medication Adherence; Middle Aged; Odds Ratio; Olmesartan Medoxomil; Retrospective Studies; Tetrazoles | 2014 |
Single-pill combination therapy in the initial treatment of marked hypertension: a propensity-matched analysis.
Topics: Amlodipine; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Dihydropyridines; Dose-Response Relationship, Drug; Drug Combinations; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Perindopril; Propensity Score; Ramipril; Retrospective Studies; Risk Factors; Telmisartan; Tetrazoles | 2015 |
Safety and effectiveness of a fixed-dose combination of olmesartan, amlodipine, and hydrochlorothiazide in clinical practice.
Topics: Adult; Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Austria; Blood Pressure; Calcium Channel Blockers; Diuretics; Drug Combinations; Female; Germany; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Primary Health Care; Prospective Studies; Risk Factors; Tetrazoles; Time Factors; Treatment Outcome | 2015 |
Simultaneous Determination of Aliskiren Hemifumarate, Amlodipine Besylate and Hydrochlorothiazide in Spiked Human Plasma Using UPLC-MS/MS.
Topics: Amides; Amlodipine; Antihypertensive Agents; Chromatography, High Pressure Liquid; Fumarates; Humans; Hydrochlorothiazide; Limit of Detection; Liquid-Liquid Extraction; Reproducibility of Results; Tandem Mass Spectrometry | 2015 |
Novel spectrophotometric methods for simultaneous determination of Amlodipine, Valsartan and Hydrochlorothiazide in their ternary mixture.
Topics: Amlodipine; Antihypertensive Agents; Hydrochlorothiazide; Limit of Detection; Spectrophotometry; Tetrazoles; Valine; Valsartan | 2015 |
Real-world effectiveness of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide in high-risk patients and other subgroups.
Topics: Administration, Oral; Adult; Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Asia; Blood Pressure; Calcium Channel Blockers; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Middle East; Prospective Studies; Tablets; Tetrazoles; Time Factors; Treatment Outcome; Valine; Valsartan | 2015 |
[Optimizing antihypertensive therapy].
Topics: Amlodipine; Antihypertensive Agents; Drug Combinations; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Metabolic Syndrome; Randomized Controlled Trials as Topic; Tetrazoles | 2015 |
A new, rapid, stability-indicating UPLC method for separation and determination of impurities in amlodipine besylate, valsartan and hydrochlorothiazide in their combined tablet dosage form.
Topics: Amlodipine; Antihypertensive Agents; Chromatography, High Pressure Liquid; Drug Combinations; Drug Stability; Hydrochlorothiazide; Limit of Detection; Reference Standards; Reproducibility of Results; Solutions; Tablets; Valsartan | 2015 |
[Fixed combination improves compliance].
Topics: Amlodipine; Amlodipine, Valsartan Drug Combination; Drug Combinations; Humans; Hydrochlorothiazide; Hypertension; Medication Adherence; Tetrazoles; Valine | 2015 |
Development of Sustained Release "NanoFDC (Fixed Dose Combination)" for Hypertension - An Experimental Study.
Topics: Amlodipine; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Calcium Channel Blockers; Drug Carriers; Drug Liberation; Half-Life; Hydrochlorothiazide; Hypertension; Lactic Acid; Microscopy, Electron, Transmission; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Wistar; Spectroscopy, Fourier Transform Infrared; Tetrazoles | 2015 |
Continuous Wavelet Transform, a powerful alternative to Derivative Spectrophotometry in analysis of binary and ternary mixtures: A comparative study.
Topics: Algorithms; Amides; Amlodipine; Bisoprolol; Complex Mixtures; Fumarates; Hydrochlorothiazide; Reproducibility of Results; Signal Processing, Computer-Assisted; Signal-To-Noise Ratio; Spectrophotometry; Wavelet Analysis | 2015 |
Simultaneous determination of valsartan, amlodipine besylate and hydrochlorothiazide using capillary zone electrophoresis (CZE).
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Calcium Channel Blockers; Calibration; Diuretics; Drug Combinations; Electrophoresis, Capillary; Hydrochlorothiazide; Limit of Detection; Reference Standards; Reproducibility of Results; Tablets; Tetrazoles; Valine; Valsartan | 2015 |
Mean centering of double divisor ratio spectra, a novel spectrophotometric method for analysis of ternary mixtures.
Topics: Amides; Amlodipine; Analysis of Variance; Chromatography, High Pressure Liquid; Fumarates; Hydrochlorothiazide; Methanol; Models, Molecular; Reference Standards; Reproducibility of Results; Spectrophotometry; Tablets | 2016 |
Comparison of amlodipine/valsartan/hydrochlorothiazide single pill combination and free combination: adherence, persistence, healthcare utilization and costs.
Topics: Aged; Aged, 80 and over; Amlodipine; Antihypertensive Agents; Cohort Studies; Drug Combinations; Female; Hospitalization; Humans; Hydrochlorothiazide; Hypertension; Male; Medication Adherence; Middle Aged; Patient Acceptance of Health Care; Retrospective Studies; Valsartan | 2015 |
Application and validation of superior spectrophotometric methods for simultaneous determination of ternary mixture used for hypertension management.
Topics: Amlodipine; Antihypertensive Agents; Benzimidazoles; Benzoates; Drug Combinations; Hydrochlorothiazide; Hypertension; Spectrophotometry; Tablets; Telmisartan | 2016 |
Does this patient have hypertensive encephalopathy?
Topics: Amlodipine; Antihypertensive Agents; Biphenyl Compounds; Brain; Carbazoles; Carvedilol; Computed Tomography Angiography; Confusion; Creatinine; Electrocardiography; Glomerular Filtration Rate; Hallucinations; Headache; Heart; Humans; Hydrochlorothiazide; Hypertension; Hypertensive Encephalopathy; Irbesartan; Magnetic Resonance Imaging; Male; Middle Aged; Propanolamines; Renal Artery Obstruction; Spironolactone; Tetrazoles; Ultrasonography | 2016 |
Cost-benefit analysis of the polypill in the primary prevention of myocardial infarction and stroke.
Topics: Aged; Aged, 80 and over; Amlodipine; Aspirin; Cardiovascular Agents; Case-Control Studies; Cohort Studies; Cost-Benefit Analysis; Humans; Hydrochlorothiazide; Losartan; Markov Chains; Middle Aged; Myocardial Infarction; Polypharmacy; Primary Prevention; Quality-Adjusted Life Years; Simvastatin; Stroke; United Kingdom | 2016 |
Simultaneous quantitative analysis of olmesartan, amlodipine and hydrochlorothiazide in their combined dosage form utilizing classical and alternating least squares based chemometric methods.
Topics: Amlodipine; Calibration; Dosage Forms; Drug Combinations; Hydrochlorothiazide; Imidazoles; Least-Squares Analysis; Spectrophotometry; Tetrazoles | 2016 |
Resolution of overlapped spectra for the determination of ternary mixture using different and modified spectrophotometric methods.
Topics: Amides; Amlodipine; Antihypertensive Agents; Drug Combinations; Fumarates; Hydrochlorothiazide; Spectrophotometry, Ultraviolet; Tablets | 2016 |
Synergisms of cardiovascular effects between iptakalim and amlodipine, hydrochlorothiazide or propranolol in anesthetized rats.
Topics: Amlodipine; Animals; Antihypertensive Agents; Blood Pressure; Drug Synergism; Heart Rate; Hydrochlorothiazide; Hypertension; Propranolol; Propylamines; Rats | 2015 |
[Effective blood pressure control with a fixed combination].
Topics: Amlodipine; Antihypertensive Agents; Drug Combinations; Humans; Hydrochlorothiazide; Hypertension; Medication Adherence; Tetrazoles; Valine | 2016 |
Ramipril + amlodipine and ramipril + hydrochlorothiazide fixed-dose combinations in relation to patient adherence.
Topics: Amlodipine; Antihypertensive Agents; Drug Therapy, Combination; Humans; Hungary; Hydrochlorothiazide; Hypertension; Medication Adherence; Ramipril; Retrospective Studies | 2016 |
Analytical Eco-Scale for Assessing the Greenness of a Developed RP-HPLC Method Used for Simultaneous Analysis of Combined Antihypertensive Medications.
Topics: Amlodipine; Antihypertensive Agents; Benzimidazoles; Benzoates; Chromatography, High Pressure Liquid; Drug Combinations; Green Chemistry Technology; Humans; Hydrochlorothiazide; Molecular Structure; Telmisartan | 2016 |
Copeptin is increased in resistant hypertension.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Biomarkers; Biphenyl Compounds; Blood Pressure; Coronary Vasospasm; Diuretics; Female; Glomerular Filtration Rate; Glycopeptides; Humans; Hydrochlorothiazide; Hypertension; Irbesartan; Male; Middle Aged; Nephrons; Osmolar Concentration; Renin-Angiotensin System; Sex Factors; Tetrazoles; Vasopressins | 2016 |
Cost-effectiveness of the polypill versus risk assessment for prevention of cardiovascular disease.
Topics: Administration, Oral; Adult; Aged; Amlodipine; Antihypertensive Agents; Cardiovascular Diseases; Computer Simulation; Cost-Benefit Analysis; Drug Combinations; Drug Costs; Dyslipidemias; Female; Humans; Hydrochlorothiazide; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Losartan; Male; Middle Aged; Models, Economic; Primary Prevention; Quality-Adjusted Life Years; Risk Assessment; Risk Factors; Simvastatin; Tablets; Time Factors; Treatment Outcome | 2017 |
Novel Pure Component Contribution Algorithm (PCCA) and UHPLC Methods for Separation and Quantification of Amlodipine, Valsartan, and Hydrochlorothiazide in Ternary Mixture.
Topics: Algorithms; Amlodipine; Antihypertensive Agents; Chromatography, High Pressure Liquid; Hydrochlorothiazide; Tablets; Valsartan | 2017 |
Attributions to new onset catatonic symptoms, late in the course of chronic schizophrenia.
Topics: Amlodipine; Antihypertensive Agents; Antipsychotic Agents; Aripiprazole; Catatonia; Chronic Disease; GABA Modulators; Humans; Hydrochlorothiazide; Lorazepam; Male; Middle Aged; Schizophrenia; Telmisartan; Time | 2017 |
Single-Pill Triple Fixed Dose Combination Therapy with Single Component Drug Monitoring in Treatment-Resistant Hypertension: A Pilot Study.
Topics: Administration, Oral; Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Drug Combinations; Drug Monitoring; Drug Resistance; Drug Substitution; Female; Germany; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Medication Adherence; Middle Aged; Pilot Projects; Tablets; Tetrazoles; Time Factors; Treatment Outcome | 2018 |
Prior Medications and the Cardiovascular Benefits From Combination Angiotensin-Converting Enzyme Inhibition Plus Calcium Channel Blockade Among High-Risk Hypertensive Patients.
Topics: Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Blood Pressure; Calcium Channel Blockers; Cause of Death; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Sodium Chloride Symporter Inhibitors; Time Factors; Treatment Outcome | 2018 |
A retrospective study evaluating the tolerability and effectiveness of adjunctive antihypertensive drugs in patients with inadequate response to initial treatment.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Metoprolol; Middle Aged; Nebivolol; Random Allocation; Retrospective Studies; Treatment Outcome | 2018 |
Identification and structure elucidation of a new degradation impurity in the multi-component tablets of amlodipine besylate.
Topics: Amlodipine; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Chromatography, Reverse-Phase; Drug Combinations; Drug Contamination; Drug Stability; Excipients; Formaldehyde; Hydrochlorothiazide; Magnetic Resonance Spectroscopy; Molecular Structure; Spectrometry, Mass, Electrospray Ionization; Time Factors; Valsartan | 2019 |
Physiologically Based Pharmacokinetic Modeling of Fimasartan, Amlodipine, and Hydrochlorothiazide for the Investigation of Drug-Drug Interaction Potentials.
Topics: Amlodipine; Antihypertensive Agents; Biphenyl Compounds; Computer Simulation; Drug Interactions; Humans; Hydrochlorothiazide; Models, Biological; Pyrimidines; Software; Tetrazoles | 2018 |
Reliable and easy-to-use LC-MS/MS-method for simultaneous determination of the antihypertensives metoprolol, amlodipine, canrenone and hydrochlorothiazide in patients with therapy-refractory arterial hypertension.
Topics: Amlodipine; Antihypertensive Agents; Canrenone; Carbon Isotopes; Chromatography, High Pressure Liquid; Deuterium; Drug Monitoring; Drug Resistance; Humans; Hydrochlorothiazide; Hypertension; Limit of Detection; Male; Metoprolol; Middle Aged; Reproducibility of Results; Tandem Mass Spectrometry | 2019 |
Side Effects of Frequently Used Antihypertensive Drugs on Wound Healing in vitro.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Calcium Channel Blockers; Cell Line; Cell Movement; Diuretics; Fibroblasts; Humans; Hydrochlorothiazide; Keratinocytes; Metoprolol; Ramipril; Tetrazoles; Wound Healing | 2019 |
A new strategy for taste masking on bitter drug by other combined drug in fixed-dose combination: bitterness of Amlodipine besylate could be masked efficiently by Valsartan.
Topics: Amlodipine; Benzazepines; Captopril; Dose-Response Relationship, Drug; Humans; Hydrochlorothiazide; Taste; Taste Perception; Telmisartan; Valsartan | 2019 |
In black Africans with hypertension, amlodipine-based therapy vs perindopril-hydrochlorothiazide improved BP control.
Topics: Amlodipine; Antihypertensive Agents; Black People; Blood Pressure; Humans; Hydrochlorothiazide; Hypertension; Perindopril | 2019 |
Effects of Different Antihypertensive Drug Combinations on Blood Pressure and Arterial Stiffness.
Topics: Aged; Amlodipine; Antihypertensive Agents; Arteries; Blood Pressure; Diastole; Drug Combinations; Essential Hypertension; Female; Humans; Hydrochlorothiazide; Lisinopril; Losartan; Male; Middle Aged; Prospective Studies; Pulse Wave Analysis; Systole; Valsartan; Vascular Resistance; Vascular Stiffness | 2019 |
Comparative effectiveness of combination treatment for hypertension in black Africans.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Black People; Calcium Channel Blockers; Comparative Effectiveness Research; Controlled Clinical Trials as Topic; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Perindopril | 2020 |
The smoothness index: an 'all purposes' approach to the assessment of the homogeneity of 24-h blood pressure control?
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Hydrochlorothiazide; Losartan; Pulse Wave Analysis | 2019 |
Pharmacokinetic and pharmacodynamic evaluation of nano-fixed dose combination for hypertension.
Topics: Amlodipine; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Disease Models, Animal; Drug Combinations; Hydrochlorothiazide; Hypertension; Male; Nanoparticles; Rats; Rats, Wistar; Tetrazoles | 2020 |
Real-World Effectiveness and Safety of a Single-Pill Combination of Olmesartan/Amlodipine/Hydrochlorothiazide in Korean Patients with Essential Hypertension (RESOLVE): A Large, Observational, Retrospective, Cohort Study.
Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Antihypertensive Agents; Asian People; Cohort Studies; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Essential Hypertension; Female; Humans; Hydrochlorothiazide; Imidazoles; Male; Middle Aged; Republic of Korea; Retrospective Studies; Tetrazoles | 2020 |
High performance liquid chromatographic assay of amlodipine, valsartan and hydrochlorothiazide simultaneously and its application to pharmaceuticals, urine and plasma analysis.
Topics: Amlodipine; Chromatography, High Pressure Liquid; Hydrochlorothiazide; Limit of Detection; Linear Models; Reproducibility of Results; Tablets; Valsartan | 2020 |
Development and Validation of a UPLC-DAD Method for the Simultaneous Quantification of Eight Antihypertensive Drugs in the Pharmaceutical Matrix.
Topics: Amlodipine; Antihypertensive Agents; Humans; Hydrochlorothiazide; Pharmaceutical Preparations; Tetrazoles; Valsartan | 2021 |
Advanced eco-friendly UV spectrophotometric approach for resolving overlapped spectral signals of antihypertensive agents in their binary and tertiary pharmaceutical dosage form.
Topics: Amlodipine; Antihypertensive Agents; Hydrochlorothiazide; Spectrophotometry; Tablets; Telmisartan | 2021 |
Combination of atorvastatin or hydrochlorothiazide/amlodipine with
Topics: Amlodipine; Atherosclerosis; Atorvastatin; Drugs, Chinese Herbal; Humans; Hydrochlorothiazide; Hyperlipidemias; Hypertension; Pueraria; Salvia miltiorrhiza | 2021 |
Development and validation of a stability-indicating UPLC method for the determination of olmesartan medoxomil, amlodipine and hydrochlorothiazide degradation impurities in their triple-combination dosage form using factorial design of experiments.
Topics: Amlodipine; Chromatography, High Pressure Liquid; Drug Contamination; Drug Stability; Hydrochlorothiazide; Limit of Detection; Linear Models; Olmesartan Medoxomil; Reproducibility of Results; Research Design; Tablets | 2021 |
Risk and DoE-Based DMAIC Principle to the Multipurpose-RP-HPLC Method for Synchronous Estimation of Anti-Hypertensive Drugs Using AQbD Approach.
Topics: Amlodipine; Antihypertensive Agents; Chromatography, High Pressure Liquid; Humans; Hydrochlorothiazide; Quality Control | 2021 |
Formulation development and in vitro characterization of triple layer tablet containing amlodipine besylate, rosuvastatin calcium and hydrochlorothiazide.
Topics: Amlodipine; Calorimetry, Differential Scanning; Drug Combinations; Drug Compounding; Drug Liberation; Hardness; Hydrochlorothiazide; Microscopy, Electron, Scanning; Rosuvastatin Calcium; Tablets | 2021 |
Management of American Heart Association/American College of Cardiology-Defined Stage 2 Hypertension by Cardiologists in India.
Topics: American Heart Association; Amlodipine; Antihypertensive Agents; Blood Pressure; Cardiologists; Cardiology; Humans; Hydrochlorothiazide; Hypertension; India; Middle Aged; Retrospective Studies; Treatment Outcome | 2022 |
Simultaneous determination of hydrochlorothiazide, amlodipine, and telmisartan with spectrophotometric and HPLC green chemistry applications.
Topics: Amlodipine; Chromatography, High Pressure Liquid; Humans; Hydrochlorothiazide; Leukemia, Myeloid, Acute; Telmisartan | 2022 |
Eco-friendly spectrophotometric evaluation of triple-combination therapies in the treatment strategy of patients suffering from hypertension during coronavirus pandemic - Spectralprint recognition study.
Topics: Amlodipine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Coronavirus; Humans; Hydrochlorothiazide; Hypertension; Leukemia, Myeloid, Acute; Pandemics; Spectrophotometry; Valsartan | 2022 |
The India Hypertension Control Initiative-early outcomes in 26 districts across five states of India, 2018-2020.
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Humans; Hydrochlorothiazide; Hypertension; India; Treatment Outcome | 2023 |
Efficacy of Antihypertensive Drugs of Different Classes After Renal Denervation in Spontaneously Hypertensive Rats.
Topics: Aldosterone; Amlodipine; Animals; Antihypertensive Agents; Bisoprolol; Blood Pressure; Cardiomyopathies; Denervation; Doxazosin; Hydrochlorothiazide; Hypertension; Kidney; Male; Rats; Rats, Inbred SHR; Renin; Sympathectomy | 2023 |
Real-World Effectiveness and Safety of a Single-Pill Combination of Olmesartan/Amlodipine/Hydrochlorothiazide in Korean Patients with Hypertension and Cardiovascular Risk Factors.
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Drug Combinations; Female; Heart Disease Risk Factors; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Olmesartan Medoxomil; Prospective Studies; Republic of Korea; Risk Factors; Tetrazoles | 2023 |